Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
AIDS
    July 2018
  1. ROSSOTTI R, Maggioni M, Merli M, Orcese C, et al
    Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subject.
    AIDS. 2018;32:1727-1729.
    >> Share

  2. VERMUND SH, Kelley KF
    Impact of HIV on human papilloma virus-mediated cervical disease progression.
    AIDS. 2018;32:1715-1717.
    >> Share

  3. MASABA R, Borkowf CB, Girde S, Zeh C, et al
    Adverse fetal and infant outcomes among HIV-infected women who received either nonnucleoside reverse transcriptase inhibitor-based or protease inhibitor-based antiretroviral therapy for prevention of mother-to-child transmission.
    AIDS. 2018;32:1625-1632.
    >> Share

  4. SARAIYA N, Kanagala V, Corpuz M
    HIV-2 in the United States: rare but not forgotten.
    AIDS. 2018;32:1547-1549.
    >> Share

  5. SCHMIDT B
    The Fab-ulous IgM in neutralizing HIV-1.
    AIDS. 2018;32:1535-1536.
    >> Share

  6. LACOMBE K
    Risk of hepatocellular carcinoma after DAA treatment in cirrhotic HIV-HCV-coinfected patients: where do we stand?
    AIDS. 2018;32:1533-1534.
    >> Share

  7. MONTGOMERY ET, Stadler J, Naidoo S, Katz AWK, et al
    Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results.
    AIDS. 2018;32:1517-1525.
    >> Share

  8. MUSINGUZI N, Muwonge T, Ngure K, Katabira E, et al
    Comparison of SMS self-reported adherence with other adherence measures in a demonstration project of HIV pre-exposure prophylaxis in Kenya and Uganda.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001955.
    >> Share

  9. LIU Y, Blakely M, Sigel K, Thin TH, et al
    Biomarker P16 predicts progression risk of anal low-grade squamous intraepithelial lesions.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001957.
    >> Share

  10. HARSLOF M, Knudsen AD, Benfield T, Nordestgaard BG, et al
    No evidence of increased risk of thyroid dysfunction in well-treated people living with HIV.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001954.
    >> Share

  11. GORRY PR, Ahmad F, Mohl J, Alkhatib G, et al
    Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001953.
    >> Share

  12. KELLY H, Chikandiwa A, Warman R, Segondy M, et al
    Associations of human gene EPB41L3 DNA methylation and cervical intraepithelial neoplasia in women living with HIV-1 in Africa.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001932.
    >> Share

  13. DUARTE HA, Beck IA, Levine M, Kiptinness C, et al
    Implementation of a point mutation assay for HIV drug resistance testing in Kenya: performance, challenges, and cost.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001934.
    >> Share

  14. KOSS CA, Liu AY, Castillo-Mancilla J, Bacchetti P, et al
    Similar tenofovir hair concentrations in men and women after directly-observed: dosing of TDF/FTC: implications for PrEP adherence monitoring.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001935.
    >> Share

  15. LEE H, Wu XK, Genberg BL, Mugavero MJ, et al
    Beyond binary retention in HIV care: Predictors of the dynamic processes of patient engagement, disengagement, and re-entry into care in a US clinical cohort.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001936.
    >> Share

  16. CHANG CC, Naranbhai V, Stern J, Roche M, et al
    Variation in cell associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator BMAL-1.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001937.
    >> Share

  17. ORTEGA PAS, Saulle I, Mercurio V, Ibba SV, et al
    The interleukin 21 (IL 21)/ microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001938.
    >> Share

  18. NORET M, Balavoine S, Noret M, Pintado C, et al
    Daily or on demand oral TDF/FTC for HIV pre-exposure prophylaxis: experience from an hospital-based clinic in France.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001939.
    >> Share

  19. WORODRIA W, Ssempijja V, Hanrahan C, Ssegonja R, et al
    Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ counts.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001941.
    >> Share

  20. MSUKWA MT, Estill J, Haas AD, van Oosterhout JJ, et al
    Weight gain of HIV-exposed, uninfected children born before and after introduction of the "Option B+" programme in Malawi.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001942.
    >> Share

  21. HUNTER MD, Shenoy A, Dwork A, Elkind MSV, et al
    Brain vascular intima vulnerability among HIV-positive and negative individuals.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001943.
    >> Share

  22. LAHIRI CD, Brown NL, Ryan KJ, Acosta EP, et al
    HIV RNA persists in rectal tissue despite rapid plasma virologic suppression with dolutegravir-based therapy.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001945.
    >> Share

  23. MATSON TE, Mcginnis KA, Rubinsky AD, Frost MC, et al
    Gender and alcohol use: influences on HIV care continuum in a national cohort of patients with HIV.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001946.
    >> Share

  24. CLIFFORD GM, Siproudhis L, Piroth L, Poizot-Martin I, et al
    Determinants of high-grade anal intraepithelial lesions in HIV-positive men having sex with men.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001947.
    >> Share

  25. GOLOB JL, Stern J, Holte S, Kitahata MM, et al
    HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001948.
    >> Share

  26. ULFHAMMER G, Eden A, Mellgren A, Fuchs D, et al
    Persistent CNS immune activation following > 10 years of effective HIV antiretroviral treatment.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001950.
    >> Share

  27. ADZHUBEI AA, Anashkina AA, Tkachev YV, Kravatsky YV, et al
    Modelling interaction between HIV-1 Nef and calnexin.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001951.
    >> Share

  28. FICHT AL, Komba A, Bisimba J, Mlanga E, et al
    The time is now: closing the pediatric treatment gap and building resilience among female sex workers and their children.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001952.
    >> Share

  29. VORKOPER S, Kupfer LE, Anand N, Patel P, et al
    Building on the HIV chronic care platform to address noncommunicable diseases in sub-Saharan Africa: a research agenda.
    AIDS. 2018;32 Suppl 1:S107-S113.
    >> Share

  30. KEMP CG, Weiner BJ, Sherr KH, Kupfer LE, et al
    Implementation science for integration of HIV and non-communicable disease services in sub-Saharan Africa: a systematic review.
    AIDS. 2018;32 Suppl 1:S93-S105.
    >> Share

  31. NUGENT R, Barnabas RV, Golovaty I, Osetinsky B, et al
    Costs and cost-effectiveness of HIV/noncommunicable disease integration in Africa: from theory to practice.
    AIDS. 2018;32 Suppl 1:S83-S92.
    >> Share

  32. JOHNSON M, Wilkinson J, Gardner A, Kupfer LE, et al
    Global partnerships to support noncommunicable disease care in low and middle-income countries: lessons from HIV/AIDS.
    AIDS. 2018;32 Suppl 1:S75-S82.
    >> Share

  33. JUMA K, Reid M, Roy M, Vorkoper S, et al
    From HIV prevention to non-communicable disease health promotion efforts in sub-Saharan Africa: A Narrative Review.
    AIDS. 2018;32 Suppl 1:S63-S73.
    >> Share

  34. PASTAKIA SD, Tran DN, Manji I, Wells C, et al
    Building reliable supply chains for noncommunicable disease commodities: lessons learned from HIV and evidence needs.
    AIDS. 2018;32 Suppl 1:S55-S61.
    >> Share

  35. RABKIN M, de Pinho H, Michaels-Strasser S, Naitore D, et al
    Strengthening the health workforce to support integration of HIV and noncommunicable disease services in sub-Saharan Africa.
    AIDS. 2018;32 Suppl 1:S47-S54.
    >> Share

  36. RABKIN M, Palma A, McNairy ML, Gachuhi AB, et al
    Integrating cardiovascular disease risk factor screening into HIV services in Swaziland: lessons from an implementation science study.
    AIDS. 2018;32 Suppl 1:S43-S46.
    >> Share

  37. NJUGUNA B, Vorkoper S, Patel P, Reid MJA, et al
    Models of integration of HIV and noncommunicable disease care in sub-Saharan Africa: lessons learned and evidence gaps.
    AIDS. 2018;32 Suppl 1:S33-S42.
    >> Share

  38. MATANJE MWAGOMBA BL, Ameh S, Bongomin P, Juma PA, et al
    Opportunities and challenges for evidence-informed HIV-noncommunicable disease integrated care policies and programs: lessons from Malawi, South Africa, Swaziland and Kenya.
    AIDS. 2018;32 Suppl 1:S21-S32.
    >> Share

  39. PATEL P, Rose CE, Collins PY, Nuche-Berenguer B, et al
    Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis.
    AIDS. 2018;32 Suppl 1:S5-S20.
    >> Share

  40. EL-SADR WM, Goosby E
    Building on the HIV platform: tackling the challenge of noncommunicable diseases among persons living with HIV.
    AIDS. 2018;32 Suppl 1:S1-S3.
    >> Share

  41. HEFFRON R, Mugo N, Hong T, Celum C, et al
    Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention.
    AIDS. 2018;32:1707-1713.
    >> Share

    June 2018
  42. MENDOZA MCB, Gardner L, Armon C, Rose C, et al
    Time spent with HIV viral load >1500 copies/mL among patients in HIV care, 2000-2014.
    AIDS. 2018 Jun 28. doi: 10.1097/QAD.0000000000001921.
    >> Share

  43. GRAYHACK C, Sheth A, Kirby O, Davis J, et al
    Evaluating outcomes of mother-infants pairs using dolutegravir for HIV treatment during pregnancy.
    AIDS. 2018 Jun 25. doi: 10.1097/QAD.0000000000001931.
    >> Share

  44. CHAMPENOIS K, Seng R, Persoz A, Essat A, et al
    Recent trends in sexual behaviours among MSM followed since primary HIV-1 infection.
    AIDS. 2018 Jun 20. doi: 10.1097/QAD.0000000000001916.
    >> Share

  45. BERETTA M, Moreau A, Bouvin-Pley M, Essat A, et al
    Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains.
    AIDS. 2018 Jun 20. doi: 10.1097/QAD.0000000000001906.
    >> Share

  46. HOY JF, Richardson R, Ebeling PR, Rojas J, et al
    Zoledronic acid is superior to tenofovir DF-switching for low bone mineral density in adults with HIV: a randomised trial.
    AIDS. 2018 Jun 20. doi: 10.1097/QAD.0000000000001911.
    >> Share

  47. SIMMS V, Rylance S, Bandason T, Dauya E, et al
    CD4 count recovery following initiation of HIV antiretroviral therapy in older childhood and adolescence.
    AIDS. 2018 Jun 20. doi: 10.1097/QAD.0000000000001905.
    >> Share

  48. AHMAD A, Mehraj V, Jenabian MA, Routy JP, et al
    Anti-Gag antibodies gag HIV infection and slow disease progression.
    AIDS. 2018;32:1373-1375.
    >> Share

  49. ROBBINS HA
    Lung cancer screening in people living with HIV: modeling to bridge the evidence.
    AIDS. 2018;32:1369-1371.
    >> Share

  50. HUGHES RA, May MT, Tilling K, Taylor N, et al
    Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio.
    AIDS. 2018;32:1361-1367.
    >> Share

  51. PRESTI RM, Handley SA, Droit L, Ghannoum M, et al
    Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status.
    AIDS. 2018;32:1279-1287.
    >> Share

  52. KOUYOUMJIAN SP, Heijnen M, Chaabna K, Mumtaz GR, et al
    Global population-level association between herpes simplex virus 2 prevalence and HIV prevalence.
    AIDS. 2018;32:1343-1352.
    >> Share

  53. HAWKINS KL, Zhang L, Ng DK, Althoff KN, et al
    Abdominal obesity, sarcopenia, and osteoporosis are associated with frailty in men living with and without HIV.
    AIDS. 2018;32:1257-1266.
    >> Share

  54. ZHANG Y, Fogel JM, Guo X, Clarke W, et al
    Antiretroviral drug use and HIV drug resistance among MSM and transgender women in sub-Saharan Africa.
    AIDS. 2018;32:1301-1306.
    >> Share

  55. ATTIA EF, Maleche-Obimbo E, West TE, Ndukwe-Wambutsi L, et al
    Adolescent age is an independent risk factor for abnormal spirometry among people living with HIV in Kenya.
    AIDS. 2018;32:1353-1359.
    >> Share

  56. HU J, Geldsetzer P, Steele SJ, Matthews P, et al
    The impact of lay counselors on HIV testing rates: Quasi-experimental evidence from lay counselor redeployment in KwaZulu-Natal, South Africa.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001924.
    >> Share

  57. SAXENA V, Ghate M, Bichare S, Khan I, et al
    Increased degranulation of immune cells is associated with higher cervical viral load in HIV infected women.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001925.
    >> Share

  58. RUEGAMER T, Hoffmann R, Rohrhofer A, Audebert F, et al
    Inhibition of HIV-1 infection by HPgV-1 derived peptides is affected by HPgV-1 genotype and HIV-1 coreceptor tropism.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001926.
    >> Share

  59. SOONTORNNIYOMKIJ V, Umlauf A, Soontornniyomkij B, Gouaux B, et al
    Association of antiretroviral therapy with brain aging changes among HIV-infected adults.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001927.
    >> Share

  60. PETERS L, Laut K, Resnati C, Del Campo S, et al
    Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001928.
    >> Share

  61. RUBIN LH, Phan KL, Keating SM, Maki PM, et al
    A single low-dose of hydrocortisone enhances cognitive functioning in HIV-infected women.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001930.
    >> Share

  62. CHHABRA S, Underwood J, Cole JH, Caan M, et al
    Clinical research cerebral MRI findings in HIV positive subjects and appropriate controls.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001910.
    >> Share

  63. VALVERDE EE, Beer L, Johnson CH, Baugher A, et al
    Changes in perceived discrimination in healthcare settings reported by HIV patients in the United States from 1996 to 2011-2013.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001908.
    >> Share

  64. DE LEOTOING L, Yazdanpanah Y, Finkielsztejn L, Chaize G, et al
    Costs Associated with Hospitalisation in Hiv-Positive Patients in France.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001907.
    >> Share

  65. DE NEVE JW, Karlsson O, Coetzee L, Schroder H, et al
    Antiretroviral therapy coverage associated with increased co-residence between elderly people and prime-age adults in Africa.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001917.
    >> Share

  66. OSMAN N, Mesplede T, Oliveira M, Hassounah S, et al
    Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washout.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001903.
    >> Share

  67. PAPASAVVAS E, Lada SM, Joseph J, Yin X, et al
    Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001909.
    >> Share

  68. D'ELBEE M, Indravudh PP, Mwenge L, Kumwenda MM, et al
    Preferences for linkage to HIV care services following a reactive self-test: discrete choice experiments in Malawi and Zambia.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001918.
    >> Share

  69. PYRA M, Anderson PL, Hendrix CW, Heffron R, et al
    Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral pre-exposure prophylaxis.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001922.
    >> Share

  70. HUGHES AJ, Rector A, Jimenez V, Brock J, et al
    Cumulative plasma HIV burden disparities among adults in HIV care: implications for HIV transmission in the era of treatment as prevention.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001914.
    >> Share

  71. SEATLA KK, Avalos A, Moyo S, Mine M, et al
    Four class drug resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir based antiretroviral therapy in Botswana.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001920.
    >> Share

  72. XIA Q, Abraham B, Shah D, Ramaswamy C, et al
    Transition from pediatric to adult care among persons with perinatal HIV infection in New York City, 2006-2015.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001923.
    >> Share

  73. DIJKSTRA M, van Lunsen RHW, Kooij KW, Davidovich U, et al
    HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapy.
    AIDS. 2018;32:1137-1146.
    >> Share

  74. CHOW FC, Wilson MR, Wu K, Ellis RJ, et al
    Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort.
    AIDS. 2018;32:1125-1135.
    >> Share

    May 2018
  75. SHAPIRO AE, Hong T, Govere S, Thulare H, et al
    C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001902.
    >> Share

  76. WOOLNOUGH EL, Hoy JF, Cheng AC, Walker RG, et al
    Predictors of chronic kidney disease and utility of risk prediction scores in HIV positive individuals.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001901.
    >> Share

  77. RONIT A, Hatleberg CI, Ryom L, Bonnet F, et al
    Associations between serum albumin and serious non-AIDS events among people living with HIV.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001900.
    >> Share

  78. MILLS EJ, Adhvaryu A, Jakiela P, Birungi J, et al
    Unconditional cash transfers for clinical and economic outcomes among HIV-affected Ugandan households: a bayesian randomised trial.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001899.
    >> Share

  79. JAFFE HW
    Lessons from the early HIV/AIDS epidemic.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001877.
    >> Share

  80. KOLBER MA
    HIV solid organ transplantation: looking beyond HOPE.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001892.
    >> Share

  81. SIEDNER MJ, Hettema A, Hughey A, Oldenburg CE, et al
    Preference for injectable over oral HIV pre-exposure prophylaxis in public-sector primary-care clinics in Swaziland.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001859.
    >> Share

  82. LE ROUX S, Donald K, Brittain K, Phillips TK, et al
    Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa: a prospective cohort.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001872.
    >> Share

  83. GLESBY MJ, Hanna DB, Hoover DR, Shi Q, et al
    Abdominal fat depots, insulin resistance, and incident diabetes mellitus in women with and without HIV infection.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001873.
    >> Share

  84. WU M, Fatukasi O, Yang S, Alger J, et al
    HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001891.
    >> Share

  85. BARTLETT AW, Khanh TH, Songtaweesin WN, Chokephaibulkit K, et al
    Characteristics, mortality and outcomes at transition for adolescents with perinatal HIV infection in Asia.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001883.
    >> Share

  86. LINDGREN AA, Filipowicz AR, Hattler JB, Kim SO, et al
    Lentiviral infection of proliferating brain macrophages in HIV and simian immunodeficiency virus encephalitis despite sterile alpha motif and histidine-aspartate domain-containing protein 1 expression.
    AIDS. 2018;32:965-974.
    >> Share

  87. MOLSBERRY SA, Cheng Y, Kingsley L, Jacobson L, et al
    Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001865.
    >> Share

  88. KILBURN K, Ranganathan M, Stoner MCD, Hughes JP, et al
    Transactional sex and incident HIV infection in a cohort of young women from rural South Africa enrolled in HPTN 068.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001866.
    >> Share

  89. HEFFRON R, Mugo N, Hong T, Celum C, et al
    Pregnancy outcomes and infant growth among babies with in utero exposure to tenofovir-based pre-exposure prophylaxis for HIV prevention.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001867.
    >> Share

  90. MONTGOMERY ET, Stadler J, Naidoo S, Katz A, et al
    Reasons for non-adherence to the dapivirine vaginal ring: results of the MTN-032/ AHA study.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001868.
    >> Share

  91. KONG D, Wang Y, Ji P, Li W, et al
    A defucosylated bispecific multivalent molecule exhibits broad HIV-1 neutralizing activity and enhanced ADCC against reactivated HIV-1 latently infected cells.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001869.
    >> Share

  92. HARRIS TG, Rabkin M, El-Sadr WM
    Achieving the 4th 90 - Healthy Aging for People Living with HIV.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001870.
    >> Share

  93. WOODSON E, Goldberg A, Michelo C, Basu D, et al
    HIV transmission in Discordant Couples in Africa in the context of ART availability.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001871.
    >> Share

  94. DILLON SM, Guo K, Austin GL, Gianella S, et al
    A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001863.
    >> Share

  95. HOORNENBORG E, Coyer L, van Laarhoven A, Achterbergh R, et al
    Change in sexual risk behaviour after six months of pre-exposure prophylaxis use: results from the Amsterdam PrEP demonstration project.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001874.
    >> Share

  96. DUFFAU P, Ozanne A, Bonnet F, Lazaro E, et al
    Multimorbidity, age-related comorbidities and mortality: association of activation, senescence and inflammation markers in HIV adults.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001875.
    >> Share

  97. ALUISIO AR, Palaniappan A, Farquhar C, Mello MJ, et al
    Integrated HIV-injury programming: An underutilized intersection to engage young adults in HIV care in low- and middle-income countries.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001876.
    >> Share

  98. MOYO S, Gaseitsiwe S, Powis KM, Pretorius Holme M, et al
    Undisclosed antiretroviral drug use in Botswana: implication for national estimates.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001862.
    >> Share

  99. YANG J, Sharma A, Shi Q, Anastos K, et al
    Improved fracture prediction using different FRAX adjustments in HIV-infected women.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001864.
    >> Share

  100. BARNES A, Betts AC, Borton EK, Sanders JM, et al
    Cervical cancer screening among HIV infected women in an urban, U.S. safety-net healthcare system.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001881.
    >> Share

  101. TSUKAMOTO T
    Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infection.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001882.
    >> Share

  102. WINCKELMANN A, Morcilla V, Shao W, Schleimann MH, et al
    Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1 infected individuals.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001861.
    >> Share

  103. GONG S, Tomusange K, Kulkarni V, Adeniji OS, et al
    Anti-HIV IgM protects against mucosal SHIV transmission.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001857.
    >> Share

  104. CICHOWITZ C, Watt MH, Mmbaga BT
    Childbirth experiences of women living with HIV: a neglected event in the prevention of mother-to-child transmission care continuum.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001860.
    >> Share

  105. RUBIN LH, Sacktor N, Creighton J, Du Y, et al
    Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy.
    AIDS. 2018 May 9. doi: 10.1097/QAD.0000000000001858.
    >> Share

  106. EVANS VA, Van Der Sluis RM, Solomon A, Dantanarayana A, et al
    PD-1 contributes to the establishment and maintenance of HIV-1 latency.
    AIDS. 2018 May 9. doi: 10.1097/QAD.0000000000001849.
    >> Share

  107. VITORIA M, Hill A, Ford N, Doherty M, et al
    The transition to dolutegravir and other new antiretrovirals in low- and middle-income countries - what are the issues?
    AIDS. 2018 May 9. doi: 10.1097/QAD.0000000000001845.
    >> Share

  108. ROJAS J, Blanco JL, Sanchez-Palomino S, Marcos MA, et al
    A maintenance three-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity: the A-TRI-WEEK pilot trial.
    AIDS. 2018 May 9. doi: 10.1097/QAD.0000000000001843.
    >> Share

  109. JANI IV, Meggi B, Loquiha O, Tobaiwa O, et al
    Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients: a cluster-randomised trial.
    AIDS. 2018 May 8. doi: 10.1097/QAD.0000000000001846.
    >> Share

  110. YANG J, Jacobson LP, Becker JT, Levine A, et al
    Impact of glycemic status on longitudinal cognitive performance in men with and without HIV Infection.
    AIDS. 2018 May 8. doi: 10.1097/QAD.0000000000001842.
    >> Share

  111. CARLANDER C, Wagner P, Beirs AV, Yilmaz A, et al
    Suppressive antiretroviral therapy associates with effective treatment of high-grade cervical intraepithelial neoplasia.
    AIDS. 2018 May 8. doi: 10.1097/QAD.0000000000001853.
    >> Share

  112. HORVATH S, Phillips N, Heany SJ, Kobor MS, et al
    Perinatally acquired HIV infection accelerates epigenetic aging in South African adolescents.
    AIDS. 2018 May 8. doi: 10.1097/QAD.0000000000001854.
    >> Share

  113. MANICKAM C, Nwanze C, Ram DR, Shah SV, et al
    Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001855.
    >> Share

  114. HUGHES RA, May MT, Tilling K, Taylor N, et al
    Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001848.
    >> Share

  115. ADLAND E, Mori L, Laker L, Csala A, et al
    Recovery of effective hiv-specific cd4+ t-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001844.
    >> Share

  116. INVERNIZZI A, Acquistapace A, Bochicchio S, Resnati C, et al
    Correlation between inner retinal layer thickness and cognitive function in HIV: new insights from an exploratory study.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001850.
    >> Share

  117. KORHONEN C, Kimani M, Wahome E, Otieno F, et al
    Depressive symptoms and problematic alcohol and other substance use in 1,476 gay, bisexual, and other men who have sex with men at three research sites in Kenya.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001847.
    >> Share

  118. SERRANO A, El Haddad S, Moal F, Prazuck T, et al
    Dysregulation of apoptosis and autophagy gene expression in PBMCs of efficiently treated HIV-infected patients.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001851.
    >> Share

  119. JOHNSON WD, O'Leary A, Flores SA
    Per-partner condom effectiveness for men who have receptive sex with HIV-positive men.
    AIDS. 2018 May 1. doi: 10.1097/QAD.0000000000001832.
    >> Share

    April 2018
  120. MARCUS JL, Volk JE, Snowden JM
    Concerns about a study on sexually transmitted infections after initiation of HIV preexposure prophylaxis.
    AIDS. 2018;32:955-956.
    >> Share

  121. THADEN JT, Gandhi M, Okochi H, Hurt CB, et al
    Seroconversion on PrEP: a case report with segmental hair analysis for timed adherence determination.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001825.
    >> Share

  122. ERON JJ, Orkin C, Gallant J, Molina JM, et al
    A week 48 randomized phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001817.
    >> Share

  123. LEYES P, Cofan M, Gonzalez-Cordon A, de Lazzari E, et al
    Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor associated hypercholesterolaemia.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001837.
    >> Share

  124. DUCLOY C, Su B, Mayr L, Klingler J, et al
    HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001834.
    >> Share

  125. KONERU R, Bimonte-Nelson H, Ciavatta V, Haile W, et al
    Reversing interferon-alpha neurotoxicity in a HIV-associated neurocognitive disorders mouse model.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001836.
    >> Share

  126. DE OLIVEIRA F, Cappy P, Lemee V, Moisan A, et al
    Detection of numerous HIV-1/MO recombinants in France.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001814.
    >> Share

  127. CHAMIE G, Schaffer EM, Ndyabakira A, Emperador DM, et al
    Comparative effectiveness of novel non-monetary incentives to promote HIV testing: a randomized trial.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001833.
    >> Share

  128. CUADROS DF, Branscum AJ, Mukandavire Z
    Temporal stability of HIV prevalence in high burden areas regardless of declines in national HIV prevalence in Malawi and Zimbabwe.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001820.
    >> Share

  129. DEUSCH S, Serrano-Villar S, Rojo D, Martinez-Martinez M, et al
    Effects of HIV, ART and prebiotics on the active fraction of the gut microbiota.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001831.
    >> Share

  130. JACQUET JM, Peyriere H, Makinson A, Peries M, et al
    Psychoactive substances, alcohol and tobacco consumption in HIV-infected outpatients.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001830.
    >> Share

  131. ALMEIDA-BRASIL CC, Moodie EEM, Mclinden T, Hamelin AM, et al
    Medication non-adherence, multi-tablet regimens, and food insecurity are key experiences in the pathway to incomplete HIV suppression.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001822.
    >> Share

  132. MASABA R, Borkowf CB, Girde S, Zeh C, et al
    Adverse fetal and infant outcomes among HIV-infected women who received either NNRTI- or PI-based ART for PMTCT.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001816.
    >> Share

  133. GEORGE VK, Pallikkuth S, Pahwa R, de Armas L, et al
    Circulating inflammatory monocytes contribute to impaired influenza vaccine responses in HIV-infected participants.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001821.
    >> Share

  134. KONG CY, Sigel K, Criss SD, Sheehan DF, et al
    Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ >/= 500: a simulation study.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001818.
    >> Share

  135. OLESEN JS, Jespersen S, Da Silva ZJ, Rodrigues A, et al
    HIV-2 continues to decrease, while HIV-1 is stabilizing in Guinea-Bissau.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001827.
    >> Share

  136. BULL ME, Mitchell C, Soria J, Styrchak S, et al
    Monotypic low-level HIV viremias during ART are associated with disproportionate production of X4 virions and systemic immune activation.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001824.
    >> Share

  137. MISSAILIDIS C, Neogi U, Stenvinkel P, Troseid M, et al
    The microbial metabolite TMAO in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages.
    AIDS. 2018 Apr 3. doi: 10.1097/QAD.0000000000001813.
    >> Share

  138. CHUNG A, Makuba JM, Ndlovu B, Licht A, et al
    Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.
    AIDS. 2018 Apr 3. doi: 10.1097/QAD.0000000000001812.
    >> Share

    March 2018
  139. ROBINSON-PAPP J, Nmashie-Osei A, Pedowitz E, Benn EKT, et al
    Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001802.
    >> Share

  140. PRESTI RM, Handley S, Droit L, Ghannoum M, et al
    Alterations in the oral microbiome in HIV-infected participants after ART administration are influenced by immune status.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001811.
    >> Share

  141. WILKINSON JD, Williams PL, Yu W, Colan SD, et al
    Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001810.
    >> Share

  142. BASTEN M, Heijne JCM, Geskus R, Daas CD, et al
    Sexual risk behaviour trajectories among men who have sex with menat risk for HIV in Amsterdam, the Netherlands: a 10 year follow-up study.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001803.
    >> Share

  143. MERCHANTE N, Rodriguez-Arrondo F, Revollo B, Merino E, et al
    Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/HCV-coinfected patients.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001809.
    >> Share

  144. SHI L, Yu L, Zhong D, Gu C, et al
    TMC120 displayed potent cytotoxic effect on human cervical carcinoma through enhancing the polymerization of microtubules.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001808.
    >> Share

  145. DEHGHAN MANSHADI SA, SeyedAlinaghi S, Mousavi SA, Salehi MR, et al
    John Cunningham virus large T antigen detection in brain biopsy of an HIV-infected patient with glioblastoma multiforme: more than a coincidental finding.
    AIDS. 2018;32:830-833.
    >> Share

  146. SORTINO O, Richards E, Dias J, Leeansyah E, et al
    IL-7 treatment supports CD8+ mucosa-associated invariant T-cell restoration in HIV-1-infected patients on antiretroviral therapy.
    AIDS. 2018;32:825-828.
    >> Share

  147. JUSTICE AC, Gordon KS, Skanderson M, Edelman EJ, et al
    Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals.
    AIDS. 2018;32:739-749.
    >> Share

  148. VALENCIA J, Ryan P, Alvaro-Meca A, Troya J, et al
    High HIV seroconversion rate in HCV-infected drug users followed in a Harm Reduction Unit: A lost opportunity for Pre- exposure Prophylaxis.
    AIDS. 2018 Mar 20. doi: 10.1097/QAD.0000000000001806.
    >> Share

  149. PALELLA F JR, Li X, Gupta SK, Estrella MM, et al
    Long-term kidney function, proteinuria, and associated risks among HIV-infected and uninfected men.
    AIDS. 2018 Mar 20. doi: 10.1097/QAD.0000000000001807.
    >> Share

  150. KROEZE S, Ondoa P, Kityo CM, Siwale M, et al
    Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001801.
    >> Share

  151. DIJKSTRA M, Van Lunsen RHW, Kooij KW, Davidovich U, et al
    HIV-1 status is independently associated with decreased erectile function among middle-aged men who have sex with men in the era of cART.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001800.
    >> Share

  152. CHOW FC, Wilson MR, Wu K, Ellis RJ, et al
    Stroke incidence is highest in women and non-Hispanic Blacks living with HIV in the ALLRT cohort.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001799.
    >> Share

  153. AZIZ SAA, Mcstea M, Bashah NSA, Chong ML, et al
    Assessment of sarcopenia in virally suppressed HIV-infected Asians receiving treatment.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001798.
    >> Share

  154. TARANCON-DIEZ L, Pablo-Bernal RS, Jimenez JL, Alvarez-Rios AI, et al
    Role of TLR4 Asp299Gly polymorphism in the development of cardiovascular diseases in HIV-infected patients.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001797.
    >> Share

  155. THAKUR KT, Boubour A, Saylor D, Das M, et al
    Global HIV neurology: a comprehensive review.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001796.
    >> Share

  156. GARCIA-PAYA E, Fernandez M, Padilla S, Garcia JA, et al
    High-grade anal intraepithelial neoplasia is associated with HIV-1 RNA rectal shedding in virologically suppressed men who have sex with men.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001794.
    >> Share

  157. CLUVER L, Meinck F, Toska E, Orkin FM, et al
    Multi-type violence exposures and adolescent antiretroviral non-adherence in South Africa.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001795.
    >> Share

  158. MEYER-RATH G, McGillen JB, Cuadros DF, Hallett TB, et al
    Targeting the right interventions to the right people and places: the role of geospatial analysis in HIV programme planning.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001792.
    >> Share

  159. ALESSANDRI-GRADT E, De Oliveira F, Leoz M, Lemee V, et al
    HIV-1 group P infection: towards a dead-end infection?
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001791.
    >> Share

  160. LINDGREN AA, Filipowicz AR, Hattler JB, Kim SO, et al
    Lentiviral infection of proliferating brain macrophages in SIV and HIV encephalitis despite SAMHD1 expression.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001793.
    >> Share

  161. CHAUDHURY S, Mayondi GK, Williams PL, Leidner J, et al
    In utero exposure to antiretrovirals and neurodevelopment among HIV-exposed uninfected children in Botswana.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001790.
    >> Share

  162. ABRAHAM AG, Zhang L, Calkins K, Tin A, et al
    Vitamin D status and immune function reconstitution in HIV-infected men initiating therapy in the Multicenter AIDS cohort study.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001782.
    >> Share


  163. Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects: Erratum.
    AIDS. 2018;32:685.
    >> Share


  164. Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals: Erratum.
    AIDS. 2018;32:681.
    >> Share


  165. Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection: Erratum.
    AIDS. 2018;32:679.
    >> Share

  166. ISMAIL MF, Wong DK, Bogoch II
    The role for hepatitis A vaccination in HIV pre-exposure prophylaxis.
    AIDS. 2018;32:675-676.
    >> Share

  167. POIZOT-MARTIN I, Laroche H, Cano CE, Nicolino-Brunet C, et al
    Cancer risk in HIV-infected patients: elite controllers are also concerned.
    AIDS. 2018;32:673-675.
    >> Share

  168. OLDENBURG CE, Chanda MM, Ortblad KF, Mwale M, et al
    Effect of HIV self-testing on the number of sexual partners among female sex workers in Zambia.
    AIDS. 2018;32:645-652.
    >> Share

    February 2018

  169. Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial: Erratum.
    AIDS. 2018;32:537.
    >> Share

  170. COGHILL AE, Schenk JM, Mahkoul Z, Orem J, et al
    Omega-3 decreases IL-6 levels in HIV and human herpesvirus-8 coinfected patients in Uganda.
    AIDS. 2018;32:505-512.
    >> Share

  171. MCMAHON CN, Petoumenos K, Hesse K, Carr A, et al
    High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years.
    AIDS. 2018;32:451-459.
    >> Share

  172. MCNULTY MC, Schneider JA
    Care continuum entry interventions: seek and test strategies to engage persons most impacted by HIV within the United States.
    AIDS. 2018;32:407-417.
    >> Share

  173. O'HALLORAN JA, Dunne E, Tinago W, Denieffe S, et al
    Switching from abacavir to tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet-collagen interactions.
    AIDS. 2018 Feb 12. doi: 10.1097/QAD.0000000000001783.
    >> Share

  174. MORA-PERIS B, Bouliotis G, Ranjababu K, Clarke A, et al
    Changes in Cerebral Function Parameters with Maraviroc Intensified Antiretroviral Therapy in Treatment Naive HIV-Positive Individuals; A Randomised Controlled Study.
    AIDS. 2018 Feb 12. doi: 10.1097/QAD.0000000000001786.
    >> Share

  175. MORAN CA, Sheth AN, Mehta CC, Hanna DB, et al
    The association of C-reactive protein with subclinical cardiovascular disease in HIV-infected and HIV-uninfected women.
    AIDS. 2018 Feb 12. doi: 10.1097/QAD.0000000000001785.
    >> Share

  176. MEDRANO LM, Garcia-Broncano P, Berenguer J, Gonzalez-Garcia J, et al
    Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/HCV-coinfected patients.
    AIDS. 2018 Feb 12. doi: 10.1097/QAD.0000000000001787.
    >> Share

  177. TABB ZJ, Mmbaga BT, Gandhi M, Louie A, et al
    Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.
    AIDS. 2018 Feb 12. doi: 10.1097/QAD.0000000000001788.
    >> Share

  178. PRADAT P, Huleux T, Raffi F, Delobel P, et al
    Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV.
    AIDS. 2018 Feb 12. doi: 10.1097/QAD.0000000000001789.
    >> Share

  179. WRIGHT EJ, Grund B, Robertson KR, Cysique L, et al
    No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001778.
    >> Share

  180. GUERRI-FERNANDEZ R, Lerma-Chippirraz E, Fernandez Marron A, Garcia-Giralt N, et al
    Bone density, microarchitecture and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001780.
    >> Share

  181. LEPIK KJ, Yip B, Ulloa A, Wang L, et al
    Adverse drug reactions to integrase strand transfer inhibitors.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001781.
    >> Share

  182. WHITE K, Garner W, Wei L, Eron JJ, et al
    Repeat testing of low-level HIV-1 RNA: assay performance and implementation in clinical trials.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001779.
    >> Share

  183. KENNEDY MC, Kerr TH, Wood E, Shoveller JA, et al
    Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001777.
    >> Share

  184. RIPAMONTI D, Zazzi M
    Rethinking recycling nucleoside reverse transcriptase inhibitors in HIV treatment: learning from the MODIBIP study.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001776.
    >> Share

  185. FOURMAN LT, Czerwonka N, Shaikh SD, Stanley TL, et al
    Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001775.
    >> Share

  186. PALLIKKUTH S, De Armas LR, Pahwa R, Rinaldi S, et al
    Impact of aging and HIV infection on serologic response to seasonal influenza vaccination.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001774.
    >> Share

  187. WEINBERG A, Huang S, Moscicki AB, Saah A, et al
    Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001773.
    >> Share

  188. WOOD S, Ratcliffe S, Gowda C, Lee S, et al
    Impact of insurance coverage on HIV transmission potential among antiretroviral therapy-treated youth living with HIV.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001772.
    >> Share

  189. EPELDEGUI M, Magpantay L, Guo Y, Halec G, et al
    A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001771.
    >> Share

  190. GANTNER P, Barnig C, Partisani M, Lee GQ, et al
    Distribution and reduction magnitude of HIV-DNA burden in CD4+ T cell subsets depend on art initiation timing.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001770.
    >> Share

  191. MITCHELL KM, Dimitrov D, Hughes JP, Xia F, et al
    In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001766.
    >> Share

  192. EASTMENT MC, McClelland RS
    Vaginal microbiota and susceptibility to HIV.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001768.
    >> Share

  193. PATEL CJ, Bhattacharya J, Ioannidis JPA, Bendavid E, et al
    Systematic identification of correlates of HIV infection: an X-wide association study.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001767.
    >> Share

  194. TITANJI K, Vunnava A, Foster A, Sheth AN, et al
    T-cell receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001764.
    >> Share

    January 2018
  195. DUNCAN CJA, Charlton FG, Bower M, Price DA, et al
    The unholy trinity of human herpesvirus 8-associated malignancy in a person living with HIV-1.
    AIDS. 2018;32:404-406.
    >> Share

  196. MINGUEZ C, Garcia-Deltoro M, Flores J, Galindo MJ, et al
    Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients.
    AIDS. 2018;32:337-346.
    >> Share

  197. LIU G, Sharma M, Tan N, Barnabas R, et al
    HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: a systematic review and meta-analysis.
    AIDS. 2018 Jan 24. doi: 10.1097/QAD.0000000000001765.
    >> Share

  198. ANDERSSON E, Nordquist A, Esbjornsson J, Flamholc L, et al
    Increase in transmitted drug resistance in migrants from Sub Saharan Africa diagnosed with HIV-1 in Sweden.
    AIDS. 2018 Jan 24. doi: 10.1097/QAD.0000000000001763.
    >> Share

  199. BILLIOUX VG, Grabowski MK, Ssekasanvu J, Reynolds SJ, et al
    HIV viral suppression and geospatial patterns of HIV antiretroviral therapy treatment facility use in Rakai, Uganda.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001761.
    >> Share

  200. DEFILIPPI C, Lo J, Christenson R, Grundberg I, et al
    Novel mediators of statin effects on plaque in HIV: a proteomics approach.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001762.
    >> Share

  201. SORTINO O, Richards E, Dias J, Leeansyah E, et al
    IL-7 treatment supports CD8+ MAIT cell restoration in HIV-1 infected patients on ART.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001760.
    >> Share

  202. HARGREAVES JR, Krishnaratne S, Mathema H, Lilleston PS, et al
    Individual and community-level risk factors for HIV stigma in 21 Zambian and South African communities: analysis of data from the HPTN071 (PopART) study.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001757.
    >> Share

  203. THOMSEN D, Erikstrup C, Jespersen S, Medina C, et al
    The influence of HLA-types on disease progression among HIV-2 infected patients in Guinea-Bissau.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001758.
    >> Share

  204. MULLIGAN N, Best BM, Wang J, Capparelli EV, et al
    Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001755.
    >> Share

  205. JUSTICE AC, Gordon K, Skanderson M, Edelman EJ, et al
    Non antiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001756.
    >> Share

  206. DE SILVA TI, Leligdowicz A, Carlson J, Garcia-Knight M, et al
    HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001753.
    >> Share

  207. CARRICO AW, Cherenack EM, Roach ME, Riley ED, et al
    Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001751.
    >> Share

  208. SMIT M, Olney J, Ford NP, Vitoria M, et al
    The growing burden of non-communicable disease among persons living with HIV in Zimbabwe.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001754.
    >> Share

  209. LOGEROT S, Rancez M, Charmeteau-de Muylder B, Figueiredo-Morgado S, et al
    HIV reservoir dynamics in HAART-treated poor immunological responder patients under IL-7 therapy.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001752.
    >> Share

  210. ROSSI C, Saeed S, Cox J, Vachon ML, et al
    Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001750.
    >> Share

  211. KOJIMA N, Klausner JD
    Improving management of sexually transmitted infections in those who use pre-exposure prophylaxis for human immunodeficiency virus infection.
    AIDS. 2018;32:272-275.
    >> Share

  212. ARRANZ-CASO A, Perez-Cruz F, Villa A, Sanz J, et al
    Kaposi sarcoma presenting shortly after primary infection by HIV and human herpesvirus-8.
    AIDS. 2018;32:271-275.
    >> Share

  213. MAGGIOLO F, Di Filippo E, Comi L, Callegaro A, et al
    Post treatment controllers after treatment interruption in chronically HIV infected patients.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001743.
    >> Share

  214. OLDENBURG C, Chanda MM, Ortblad KF, Mwale M, et al
    Effect of HIV self-testing on the number of sexual partners among female sex workers in Zambia: A randomized controlled trial.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001740.
    >> Share

  215. VELDSMAN KA, Maritz J, Isaacs S, Katusiime MG, et al
    Rapid decline of HIV-1 DNA and RNA in infants starting very early ART may pose a diagnostic challenge.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001739.
    >> Share

  216. WILLIS SJ, Cole SR, Westreich D, Edmonds A, et al
    Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001745.
    >> Share

  217. FU R, Owens DK, Brandeau ML
    Cost-effectiveness of alternative strategies for provision of HIV pre-exposure prophylaxis for people who inject drugs.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001747.
    >> Share

  218. TORRES TS, Harrison LJ, La Rosa AM, Cardoso SW, et al
    Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001738.
    >> Share

  219. OLDENBURG CE, Bor J, Harling G, Tanser F, et al
    Impact of early antiretroviral therapy eligibility on HIV acquisition: Household-level evidence from rural South Africa.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001737.
    >> Share

  220. HADDAD L, Wall KM, Kilembe W, Vwailika B, et al
    Bacterial vaginosis modifies the association between hormonal contraception and HIV acquisition.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001741.
    >> Share

  221. CILLO AR, Hong F, Tsai A, Irrinki A, et al
    Blood biomarkers of expressed and inducible HIV-1.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001748.
    >> Share

  222. BERNARDES C, Russo P, Carvalho D, Saiote J, et al
    Primary HIV infection in a Crohn's disease patient receiving infliximab maintenance therapy.
    AIDS. 2018;32:130-131.
    >> Share

  223. YOSHIMURA Y, Miyata N, Komatsu H, Tachikawa N, et al
    Remarkable plasma HIV RNA decrease by ombitasvir/paritaprevir/ritonavir in an HIV-HCV coinfection case.
    AIDS. 2018;32:128-129.
    >> Share

  224. CATTANEO D, Rizzardini G, Gervasoni C
    Psychoactive drugs and HIV: are we sure to treat our patients adequately?
    AIDS. 2018;32:127-128.
    >> Share

  225. DURAND-ZALESKI I, Mutuon P, Charreau I, Tremblay C, et al
    Costs and benefits of on-demand HIV preexposure prophylaxis in MSM.
    AIDS. 2018;32:95-102.
    >> Share

    December 2017
  226. RUBINSTEIN PG, Moore PC, Rudek MA, Henry DH, et al
    Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001729.
    >> Share

  227. RODRIGUEZ-GALLEGO E, Gomez J, Pacheco YM, Peraire J, et al
    A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of ART in HIV-infected patients.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001730.
    >> Share

  228. NICOLI F, Gallerani E, Sforza F, Finessi V, et al
    The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naive CD4+ T cells.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001734.
    >> Share

  229. ABECASIS AB, Pingarilho M, Vandamme AM
    Phylogenetic analysis as a forensic tool in HIV transmission investigations: a literature review.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001728.
    >> Share

  230. GEFFNER ME, Patel K, Jacobson DL, Wu J, et al
    Changes in Insulin Sensitivity over Time and Associated Factors in HIV-Infected Adolescents.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001731.
    >> Share

  231. LUO M, Czarnecki C, Nebroski M, Kimani J, et al
    KIR3DL1 alleles and their Epistatic Interactions with HLA Class I Influence Resistance and Susceptibility to HIV-1 acquisition in the Pumwani Sex Worker cohort.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001735.
    >> Share

  232. REIDY WJ, Rabkin M, Syowai M, Schaaf A, et al
    Patient- and program-level monitoring of differentiated service delivery for HIV: a pragmatic and parsimonious approach is needed.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001723.
    >> Share

  233. MOUNTFORD J, Octaviana F, Estiasari R, Setiawan DD, et al
    Ex vivo expression of chemokine receptors on cells surrounding cutaneous nerves in patients with HIV-associated sensory neuropathy.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001714.
    >> Share

  234. NEOGI U, Singh K, Aralaguppe SG, Rogers LC, et al
    Ex vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV-1 non-B subtypes.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001726.
    >> Share

  235. GAO N, Wang W, Wang C, Gu T, et al
    Development of broad neutralization activity in SHIV-infected rhesus macaques after long-term infection.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001724.
    >> Share

  236. SADANAND S, Das J, Chung AW, Schoen MK, et al
    Temporal variation in HIV-specific IgG subclass Abs during acute infection differentiates spontaneous controllers from chronic progressors.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001716.
    >> Share

  237. MCCOMSEY GA, Lupo S, Parks D, Poggio MC, et al
    Switch from tenofovir disoproxil fumarate combination to dolutegravir plus rilpivirine improves parameters of bone health.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001725.
    >> Share

  238. BOSER AS, Bidaud B, Maues S, Guiraud N, et al
    Addressing HIV on the French Guyanese-Brazilian border: no choice but collaboration!
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001727.
    >> Share

  239. ALTEKRUSE SF, Shiels MS, Modur SP, Land SR, et al
    Cancer burden attributable to cigarette smoking among HIV-infected people in North America.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001721.
    >> Share

  240. COGHILL AE, Schenk JM, Mahkoul Z, Orem J, et al
    Omega-3 decreases interleukin-6 levels in HIV and HHV-8 co-infected patients: results from a randomized supplementation trial in Uganda.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001722.
    >> Share

  241. CORDOVA D, Heinze J, Hsieh HF, Mistry R, et al
    Are trajectories of psychosocial risk in adolescence linked to HIV vulnerability in emerging and young adulthood? an eighteen-year longitudinal study.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001717.
    >> Share

  242. MCMAHON CN, Petoumenos K, Hesse K, Carr A, et al
    Eleven-year incident glucose disorders in treated HIV-infection. The St Vincent's HIV and Diabetes Study.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001709.
    >> Share

  243. NGUYEN VK, Greenwald ZR, Trottier H, Cadieux M, et al
    Incidence of sexually transmitted infections before and after Pre-Exposure Prophylaxis for HIV: a cohort study.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001718.
    >> Share

    November 2017
  244. MOMPLAISIR FM, Storm D, Nkwihoreze H, Jayeola O, et al
    Improving postpartum retention in care for women living with HIV in the United States.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001707.
    >> Share

  245. RIZZO MD, Crawford RB, Henriquez JE, Aldhamen Y, et al
    HIV-infected cannabis users have lower circulating CD16+ monocytes and IP-10 levels compared to non-using HIV patients.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001704.
    >> Share

  246. QIN Y, Han L, Babbitt A, Walker JS, et al
    Experiences using and organizing HIV self-testing: A global qualitative systematic review.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001705.
    >> Share

  247. FITZPATRICK ME, Kunisaki KM, Morris A
    Pulmonary Disease in HIV-Infected Adults in the Era of Antiretroviral Therapy.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001712.
    >> Share

  248. EATON EF, Tamhane A, Davy-Mendez T, Mathews WC, et al
    Trends in ART Prescription, Durability and Modification: New drugs, more changes, but less failure.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001708.
    >> Share

  249. DOMBLIDES C, Antoine M, Hamard C, Rabbe N, et al
    Non-small cell lung cancer from HIV-infected patients expressed PD-L1 with marked inflammatory infiltrates.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001713.
    >> Share

  250. LANCKI N, Almirol E, Alon L, McNulty M, et al
    PrEP guidelines have low sensitivity for identifying seroconverters in a sample of Young Black men who have sex with men in Chicago.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001710.
    >> Share

  251. GRABOWSKI MK, Reynolds S, Kagaayi J, Gray R, et al
    The validity of self-reported antiretroviral use in persons living with HIV: a population-based study.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001706.
    >> Share

  252. LI F, Ma L, Feng Y, Ruan Y, et al
    HIV-1 and Hepatitis C virus selection bottleneck in Chinese people who inject drugs.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001702.
    >> Share

  253. XIA Q, Ning Z, Torian LV
    Should we report the proportion of late HIV diagnoses?
    AIDS. 2017;31:2559-2561.
    >> Share

  254. WU UI, Hung CC, Chang SY, Jhong YT, et al
    Neutralizing antiinterferon-gamma autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy.
    AIDS. 2017;31:2557-2559.
    >> Share

  255. BRENNER BG, Baril JG
    Limiting cardiovascular events associated with HIV and antiretroviral therapy.
    AIDS. 2017;31:2551-2553.
    >> Share

  256. DHARAN NJ, Cooper DA
    Reducing medical comorbidities associated with long-term HIV infection: beyond optimizing antiretroviral therapy regimens.
    AIDS. 2017;31:2547-2549.
    >> Share

  257. KUNIHOLM MH, Liang H, Anastos K, Gustafson D, et al
    Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women.
    AIDS. 2017;31:2483-2492.
    >> Share

  258. MCGILLEN JB, Sharp A, Honermann B, Millett G, et al
    Consequences of a changing US strategy in the global HIV investment landscape.
    AIDS. 2017;31:F19-F23.
    >> Share

  259. GATELL JM, Assoumou L, Moyle G, Waters L, et al
    Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk.
    AIDS. 2017;31:2503-2514.
    >> Share


  260. Frailty in HIV infected people: a new risk factor for bone mineral density loss?: Erratum.
    AIDS. 2017;31:2441.
    >> Share

  261. SAH P, Fitzpatrick MC, Pandey A, Galvani AP, et al
    HIV criminalization exacerbates subpar diagnosis and treatment across the United States: response to the 'Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States'.
    AIDS. 2017;31:2437-2439.
    >> Share

  262. DALAL S, Johnson C, Fonner V, Kennedy CE, et al
    Reaching people with undiagnosed HIV infection through assisted partner notification.
    AIDS. 2017;31:2436-2437.
    >> Share

  263. JOSEPH DAVEY DL, Wall KM
    Need to include couples' HIV counselling and testing as a strategy to improve HIV partner notification services.
    AIDS. 2017;31:2435-2436.
    >> Share

  264. THIEBAUT R, Hue S, Le Marec F, Lelievre JD, et al
    Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients.
    AIDS. 2017;31:2355-2365.
    >> Share

  265. SIEFRIED KJ, Mao L, Cysique LA, Rule J, et al
    Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive ART.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001685.
    >> Share

  266. LODI S, Gunthard HF, Dunn D, Garcia F, et al
    Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001692.
    >> Share

  267. MAKINSON A, Hayot M, Eymard-Duvernay S, Ribet C, et al
    HIV is associated with airway obstruction: a matched controlled study.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001691.
    >> Share

  268. MATHABIRE RUCKER SC, Tayea A, Bitilinyu-Bangoh J, Bermudez-Aza EH, et al
    High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients: results from a cross-sectional survey in Malawi.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001700.
    >> Share

  269. CHOMONT N, Okoye AA, Favre D, Trautmann L, et al
    Wake me up before you go: A strategy to reduce the latent HIV reservoir.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001695.
    >> Share

  270. TRIPLETTE M, Justice A, Attia EF, Tate J, et al
    Markers of Chronic Obstructive Pulmonary Disease are associated with mortality in people living with HIV.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001701.
    >> Share

  271. INZAULE SC, Hamers RL, Calis J, Boerma R, et al
    When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001696.
    >> Share

  272. FAVARATO G, Townsend CL, Bailey H, Peters H, et al
    Protease inhibitors and preterm delivery: another piece in the puzzle.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001694.
    >> Share

  273. SHARMA M, Smith JA, Farquhar C, Ying R, et al
    Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya: A mathematical modeling analysis.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001697.
    >> Share

  274. PONGPIRUL W, Pongpirul K, Ananworanich J, Klinbuayaem V, et al
    Chronic kidney disease incidence and survival of Thai HIV-infected patients.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001698.
    >> Share

  275. MINGUEZ C, Garcia-Deltoro M, Flores J, Galindo MJ, et al
    Interferon-free therapy for treating HCV in difficult-to-treat HIV-coinfected patients as implemented in routine medical practice.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001699.
    >> Share

  276. AHMAD F, Mishra N, Ahrenstorf G, Franklin BS, et al
    Evidence of inflammasome activation and formation of monocyte-derived apoptosis-associated speck-like protein containing a caspase-recruitment domain specks in HIV-1 positive patients.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001693.
    >> Share

  277. MOCROFT A, Laut K, Reiss P, Gatell J, et al
    Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?
    AIDS. 2017 Nov 3. doi: 10.1097/QAD.0000000000001684.
    >> Share

  278. EDWARDS JK, Cole SR, Hall HI, Mathews WC, et al
    Virologic suppression and CD4 cell count recovery after initiation of raltegravir- or efavirenz- containing HIV treatment regimens.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001668.
    >> Share

  279. BEIMA-SOFIE K, Wamalwa D, Maleche-Obimbo E, Lingappa JR, et al
    Toll-Like Receptor (TLR) 9 polymorphism is associated with increased Epstein-Barr virus and Cytomegalovirus acquisition in HIV-exposed infants.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001680.
    >> Share

  280. FORD N, Migone C, Calmy A, Kerschberger B, et al
    Benefits and risks of rapid initiation of antiretroviral therapy: a systematic review and meta-analysis.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001671.
    >> Share

  281. LAVENDER KJ, Pace C, Sutter K, Messer RJ, et al
    An advanced BLT-humanized mouse model for extended HIV-1 cure studies.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001674.
    >> Share

  282. NICOL MR, Brewers LM, Kashuba AD, Sykes C, et al
    The role of menopause in tenofovir diphosphate and emtricitabine triphosphate concentrations in cervical tissue.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001678.
    >> Share

  283. BOIVIN MJ, Barlow-Mosha L, Chernoff M, Laughton B, et al
    Neuropsychological performance in African children with HIV enrolled in a multi-site anti-retroviral clinical trial.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001683.
    >> Share

  284. CID-SILVA P, Margusino-Framinan L, Balboa-Barreiro V, Martin-Herranz I, et al
    Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001679.
    >> Share

  285. CARRILLO J, Negredo E, Puig J, Molinos-Albert LM, et al
    Memory B cell dysregulation in HIV-1 infected Individuals.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001686.
    >> Share

  286. CANIGLIA EC, Zash R, Jacobson DL, Diseko M, et al
    Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001673.
    >> Share

  287. LONGENECKER CT, Sullivan CE, Morrison J, Hileman CO, et al
    The effects of HIV and smoking on aortic and splenic inflammation.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001682.
    >> Share

  288. BARDON VF, Mandelbrot L, Duro D, Dussaux C, et al
    Placental transfer of elvitegravir and cobicistat in an Ex Vivo human cotyledon double perfusion model.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001681.
    >> Share

  289. BURLACU R, Umlauf A, Luca A, Gianella S, et al
    Sex based differences in neurocognitive functioning in HIV infected young adults.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001687.
    >> Share

  290. ENGELHARD EAN, Smit C, Van Dijk PR, Kuijper TM, et al
    Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseasess.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001672.
    >> Share

  291. OLSON A, Bannert N, Sonnerborg A, de Mendoza C, et al
    Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001689.
    >> Share

    October 2017
  292. TARTAGLIA A, Ferrara SM, Sica S, Santantonio T, et al
    Successful treatment with tenofovir alafenamide of a HIV/hepatitis B virus coinfected patient with HIV and hepatitis B virus drug resistance, end-stage renal disease on haemodialysis.
    AIDS. 2017;31:2314-2315.
    >> Share

  293. VASE MO, Ludvigsen M, Bendix K, Dutoit SH, et al
    Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma.
    AIDS. 2017;31:2311-2313.
    >> Share

  294. SIEGENBEEK VAN HEUKELOM ML, Marra E, de Vries HJC, van der Loeff MFS, et al
    Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible?
    AIDS. 2017;31:2295-2301.
    >> Share

  295. TASSIOPOULOS K, Abdo M, Wu K, Koletar SL, et al
    Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults.
    AIDS. 2017;31:2287-2294.
    >> Share

  296. MIKKELSEN E, Hontelez JAC, Nonvignon J, Amon S, et al
    The costs of HIV treatment and care in Ghana.
    AIDS. 2017;31:2279-2286.
    >> Share

  297. MENZA TW, Billock R, Samoff E, Eron JJ, et al
    Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010-2016.
    AIDS. 2017;31:2235-2244.
    >> Share

  298. HOORNENBORG E, Krakower DS, Prins M, Mayer KH, et al
    Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries.
    AIDS. 2017;31:2179-2191.
    >> Share

  299. LEVINSON KL, Riedel DJ, Ojalvo LS, Chan W, et al
    Gynecologic cancer in HIV infected women: treatment and outcomes in a multi-institutional cohort.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001664.
    >> Share

  300. SABIN CA, Ryom L, d'Arminio Monforte A, Hatleberg CI, et al
    Abacavir use and risk of recurrent myocardial infarction: the D: A: D Study.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001666.
    >> Share

  301. VICENZI E, Poli G
    Chronically infected T Cell lines become handy for a novel assay measuring the reservoir of replication-competent HIV-1.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001655.
    >> Share

  302. LACOURSE SM, Pavlinac PB, Cranmer LM, Njuguna IN, et al
    Stool Xpert MTB/RIF and urine lipoarabinomannan (LAM) for diagnosing tuberculosis in hospitalized HIV-infected children.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001662.
    >> Share

  303. CREPAZ N, Tang T, Marks G, Hall HI, et al
    Changes in viral suppression status among HIV patients receiving care: United States, 2014.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001660.
    >> Share

  304. NISHIJIMA T, Mutoh Y, Kawasaki Y, Tomonari K, et al
    Cumulative exposure of tenofovir disoproxil fumarate is associated with kidney tubulopathy whether it is currently used or discontinued in HIV-infected patients.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001667.
    >> Share

  305. SANDERS EJ, Price MA, Karita E, Kamali A, et al
    Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001659.
    >> Share

  306. STAFFORD KA, Magder LS, Hungerford LL, Guralnik JM, et al
    Immunologic response to ART by age among treatment-naive patients in sub-Saharan Africa.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001663.
    >> Share

  307. GOPALAPPA C, Sansom SL, Farnham PG, Chen YH, et al
    Combinations of interventions to achieve a national HIV incidence reduction goal: insights from the agent-based PATH 2.0 model.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001653.
    >> Share

  308. DURAND-ZALESKI I, Mutuon P, Charreau I, Tremblay C, et al
    Costs and benefits of On-Demand HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men Analysis of the ANRS IPERGAY study with a one-year follow-up.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001658.
    >> Share

  309. ROCHA C, Duarte J, Borrego P, Calado R, et al
    Potency of HIV-2-specific antibodies increase in direct association with loss of memory B-cells.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001661.
    >> Share

    September 2017
  310. ZOBOLI F, Ripamonti D, Benatti SV, Comi L, et al
    Autoimmune hepatitis and HIV infection: two case reports and review of the literature.
    AIDS. 2017;31:2172-2175.
    >> Share

  311. HYLE EP, Jani IV, Rosettie KL, Wood R, et al
    The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.
    AIDS. 2017;31:2135-2145.
    >> Share

  312. LAKE AC
    Hepatitis B reactivation in a long-term nonprogressor due to nivolumab therapy.
    AIDS. 2017;31:2115-2118.
    >> Share

  313. GIANELLA S, Chaillon A, Mutlu EA, Engen PA, et al
    Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.
    AIDS. 2017;31:2059-2067.
    >> Share

  314. GOURLAY AJ, Pharris AM, Noori T, Supervie V, et al
    Towards standardized definitions for monitoring the continuum of HIV care in Europe.
    AIDS. 2017;31:2053-2058.
    >> Share

  315. JAO J, Powis KM, Kirmse B, Yu C, et al
    Lower mitochondrial DNA and altered mitochondrial fuel metabolism in hiv-exposed uninfected infants in cameroon.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001647.
    >> Share

  316. BESSON C, Lancar R, Prevot S, Algarte-Genin M, et al
    Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern cART era.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001652.
    >> Share

  317. EWING AC, King CC, Wiener JB, Chasela CS, et al
    Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001641.
    >> Share

  318. SCHEEPERS C, Chowdhury S, Wright WS, Campbell CT, et al
    Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001643.
    >> Share

  319. ANGELOVICH TA, Hearps AC, Oda MN, Borja MS, et al
    Dysfunctional HDL from HIV+ individuals promotes monocyte-derived foam cell formation in vitro.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001642.
    >> Share

  320. VAN HEUKELOM MLS, Marra E, de Vries HJC, van der Loeff MFS, et al
    Risk factors for anal HSIL in HIV-positive MSM: is targeted screening possible?
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001639.
    >> Share

  321. CHOW FC, Regan S, Zanni MV, Looby SE, et al
    Elevated ischemic stroke risk among women living with HIV infection.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001650.
    >> Share

  322. LAKE JE, Li X, Palella FJ Jr, Erlandson KM, et al
    Metabolic health across the body mass index spectrum in HIV-Infected and HIV-Uninfected Men.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001651.
    >> Share

  323. RODRIGUEZ-HART C, Nowak RG, Musci R, German D, et al
    Pathways from sexual stigma to incident HIV and sexually transmitted infections among Nigerian men who have sex with men.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001637.
    >> Share

  324. DUQUENNE C, Gimenez S, Guigues A, Viala B, et al
    Reversing HIV latency via sphingosine-1-phosphate receptor 1 signaling.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001649.
    >> Share

  325. THORNTON AC, Jose S, Bhagani S, Chadwick D, et al
    Hepatitis B, hepatitis C and mortality among HIV-positive individuals.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001646.
    >> Share

  326. MIKULAK J, Oriolo F, Zaghi E, Di Vito C, et al
    Natural Killer cells in HIV-1 infection and therapy.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001645.
    >> Share

  327. KUNIHOLM MH, Liang H, Anastos K, Gustafson D, et al
    Association of a 3' Untranslated Region Polymorphism in PCSK9 with HIV Viral Load and CD4+ Levels in HIV/Hepatitis C Virus Co-Infected Women.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001648.
    >> Share

  328. BALASUBRAMANIAN R, Fowler MG, Dominguez K, Lockman S, et al
    Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001640.
    >> Share

  329. FLORES HERRERA MF, Dauby N
    Eye compartmentalization of HIV replication and cataract risk in HIV-infected patients: is there a link?
    AIDS. 2017;31:2024-2025.
    >> Share

  330. KLATT NR, Hunt PW
    MicroRNAs: novel tools to block gut inflammation in HIV?
    AIDS. 2017;31:2017-2018.
    >> Share

  331. ALVAREZ-DEL ARCO D, Fakoya I, Thomadakis C, Pantazis N, et al
    High levels of postmigration HIV acquisition within nine European countries.
    AIDS. 2017;31:1979-1988.
    >> Share

  332. RONIT A, Kristensen T, Klitbo DM, Gelpi M, et al
    Incidental lung cancers and positive computed tomography images in people living with HIV.
    AIDS. 2017;31:1973-1977.
    >> Share

    August 2017
  333. WEINSTEIN M, Yang OO, Cohen AC
    Were we prepared for PrEP? five years of implementation.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001626.
    >> Share

  334. MEDLAND NA, Nicholson S, Chow EPF, Read THR, et al
    Time from HIV infection to virological suppression: dramatic fall from 2007-2016.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001634.
    >> Share

  335. WINTER JR, Stagg HR, Smith CJ, Brown AE, et al
    Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV from 2000 to 2014.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001635.
    >> Share

  336. ORLOVA-FINK N, Chowdhury FZ, Xiaoming S, Harrington S, et al
    Preferential susceptibility of Th9 and Th2 CD4 T cells to X4-tropic HIV-1 infection.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001630.
    >> Share

  337. RUBIN LH, Cook JA, Springer G, Weber KM, et al
    Perceived and post-traumatic stress are associated with decreased learning, memory, and fluency in HIV-infected women.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001625.
    >> Share

  338. BOCCARA F, Ghislain M, Meyer L, Goujard C, et al
    Impact of protease inhibitors on circulating PCSK9 levels in HIV-infected antiretroviral-naive patients from the ANRS COPANA cohort.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001633.
    >> Share

  339. THIEBAUT R, Hue S, Le Marec F, Lelievre JD, et al
    Serum ST2 level is an independent predictor of all-cause mortality in HIV-infected patients. Aquitaine Cohort, France.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001628.
    >> Share

  340. MCCLELLAND A, French M, Mykhalovskiy E, Gagnon M, et al
    The harms of HIV criminalization: responding to the 'association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States'.
    AIDS. 2017;31:1899-1900.
    >> Share

  341. GOLDEN MR
    Assisted partner services for HIV: ready to go global.
    AIDS. 2017;31:1891-1893.
    >> Share

  342. POPPE LK, Chunda-Liyoka C, Kwon EH, Gondwe C, et al
    HIV drug resistance in infants increases with changing prevention of mother-to-child transmission regimens.
    AIDS. 2017;31:1885-1889.
    >> Share

  343. BLASER N, Bertisch B, Kouyos RD, Calmy A, et al
    Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM.
    AIDS. 2017;31:1859-1866.
    >> Share

  344. SALADINI F, Giannini A, Boccuto A, Tiezzi D, et al
    The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001616.
    >> Share

  345. GANDHI M, Murnane PM, Bacchetti P, Elion R, et al
    Hair Levels of PrEP Drugs Measure Adherence and are Associated with Renal Decline Among Men/Transwomen in an Open Label PrEP Study.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001615.
    >> Share

  346. FOURMAN LT, Czerwonka N, Feldpausch MN, Weiss J, et al
    Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001614.
    >> Share

  347. MILLS JC, Harman JS, Cook RL, Marlow NM, et al
    Comparative effectiveness of dual vs single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001618.
    >> Share

  348. ANDERSON JC, Grace KT, Miller E
    Reproductive coercion among women living with HIV: an unexplored risk factor for negative sexual and mental health outcomes.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001620.
    >> Share

  349. LEE GQ, Bangsberg DR, Mo T, Lachowski C, et al
    Prevalence and clinical impacts of HIV-1 intersubtype recombinants in uganda revealed by a near-full-genome population and deep sequencing approaches.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001619.
    >> Share

  350. YIN MT, Chan ES, Brown TT, Tebas P, et al
    Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation: ACTG A5280.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001621.
    >> Share

  351. MENZA TW, Billock R, Samoff E, Eron JJ, et al
    Pre-treatment integrase strand transfer inhibitor resistance in north carolina from 2010-2016.
    AIDS. 2017 Aug 12. doi: 10.1097/QAD.0000000000001611.
    >> Share

  352. TASSIOPOULOS K, Abdo M, Wu K, Koletar SL, et al
    Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults: a prospective cohort study.
    AIDS. 2017 Aug 12. doi: 10.1097/QAD.0000000000001613.
    >> Share

  353. MIKKELSEN E, Hontelez J, Nonvignon J, Amon S, et al
    The costs of HIV treatment and care in Ghana: A longitudinal multi-site analysis.
    AIDS. 2017 Aug 12. doi: 10.1097/QAD.0000000000001612.
    >> Share

  354. BERARD A, Sheehy O, Zhao JP, Abrahamowicz M, et al
    Antiretroviral combination use during pregnancy and the risk of major congenital malformations.
    AIDS. 2017 Aug 12. doi: 10.1097/QAD.0000000000001610.
    >> Share

    July 2017
  355. SARIS J, van den Berk G, Moha DA, van der Meer J, et al
    Successful implementation of hepatitis C virus treatment in two large HIV clinics in Amsterdam: hepatitis C virus treatment cascade of care.
    AIDS. 2017;31:1779-1780.
    >> Share

  356. SMIT DP, Meyer D
    HIV-induced uveitis: would you recognize it if it looked straight at you?
    AIDS. 2017;31:1777-1779.
    >> Share

  357. KHELOUFI F, Boucherie Q, Blin O, Micallef J, et al
    Neuropsychiatric events and dolutegravir in HIV patients: a worldwide issue involving a class effect.
    AIDS. 2017;31:1775-1777.
    >> Share

  358. LAL L, Audsley J, Murphy DA, Fairley CK, et al
    Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users.
    AIDS. 2017;31:1709-1714.
    >> Share

  359. YOUN B, Shireman TI, Lee Y, Galarraga O, et al
    Ten-year trends in antiretroviral therapy persistence among US Medicaid beneficiaries.
    AIDS. 2017;31:1697-1707.
    >> Share

  360. CABY F
    CD4+/CD8+ ratio restoration in long-term treated HIV-1-infected individuals.
    AIDS. 2017;31:1685-1695.
    >> Share

  361. BISSON GP, Ramchandani R, Miyahara S, Mngqibisa R, et al
    Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.
    AIDS. 2017 Jul 24. doi: 10.1097/QAD.0000000000001606.
    >> Share

  362. BURGOS J, Hernandez-Losa J, Landolfi S, Guelar A, et al
    The role of oncogenic HPV determination for diagnosis of high-grade anal intraepithelial neoplasia in HIV-infected MSM.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001605.
    >> Share

  363. LEBRUN D, Hentzien M, Cuzin L, Rey D, et al
    Epidemiology of autoimmune and inflammatory diseases in a French Nationwide HIV cohort.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001603.
    >> Share

  364. PRICE JC, Dodge JL, Ma Y, Scherzer R, et al
    Controlled attenuation parameter and MR spectroscopy-measured liver steatosis are discordant in HIV-infected adults with high body mass.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001601.
    >> Share

  365. DAVEY DLJ, Bekker LG, Gorbach P, Coates T, et al
    Delivering PrEP to pregnant and breastfeeding women in sub-Saharan africa: The implementation science frontier.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001604.
    >> Share

  366. AGUDELO-HERNANDEZ A, Chen Y, Bullotta A, Buchanan WG, et al
    Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001602.
    >> Share

  367. GOURLAY AJ, Pharris AM, Noori T, Supervie V, et al
    Towards standardised definitions for monitoring the continuum of HIV care in Europe.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001597.
    >> Share

  368. DITTMER DP, Tamburro K, Chen H, Lee A, et al
    Oral shedding of Herpesviruses in HIV+ patients with varying degrees of immune status.
    AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001589.
    >> Share

  369. HAALAND RE, Martin A, Holder A, Fountain JJ, et al
    Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis.
    AIDS. 2017;31:1647-1650.
    >> Share

  370. RONIT A, Ahlstrom MG
    Publication trends during the HIV pandemic: contributions by country.
    AIDS. 2017;31:1646-1647.
    >> Share

  371. MORSE CG
    Fatty liver disease in HIV: common, underappreciated, and understudied.
    AIDS. 2017;31:1633-1635.
    >> Share

  372. HOORNENBORG E, Achterbergh RCA, Schim van der Loeff MF, Davidovich U, et al
    MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection.
    AIDS. 2017;31:1603-1610.
    >> Share

  373. RUPEREZ M, Gonzalez R, Maculuve S, Quinto L, et al
    Maternal HIV infection is an important health determinant in non-HIV-infected infants.
    AIDS. 2017;31:1545-1553.
    >> Share

  374. VANPOUILLE C, Bernatchez JA, Lisco A, Arakelyan A, et al
    A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.
    AIDS. 2017;31:1519-1528.
    >> Share

  375. ZENG H, Wang L, Liu P, Liao L, et al
    Seroprevalence of hepatitis E virus in HIV-infected patients in China.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001585.
    >> Share

  376. PHILIBERT P, Chiche L, Cailleres S, Allemand J, et al
    HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients?
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001588.
    >> Share

  377. VAN ZUMMEREN M, Kremer WW, Van Aardt MC, Breytenbach E, et al
    Selection of women at risk for cervical cancer in an HIV-infected SOUTH AFRICAN population.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001583.
    >> Share

  378. STONER MCD, Pettifor A, Edwards JK, Aiello AE, et al
    The effect of school attendance and school dropout on incident HIV and HSV-2 among young women in rural South Africa enrolled in HPTN 068.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001584.
    >> Share

  379. MCBAIN RK, Petersen E, Tophof N, Dunbar E, et al
    Impact and economic evaluation of a novel HIV service delivery model in rural Malawi.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001578.
    >> Share

  380. DONNELL D, Ramos E, Celum C, Baeten J, et al
    The Effect of Oral Pre-Exposure Prophylaxis on the Progression of HIV-1 Seroconversion.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001577.
    >> Share

  381. HYLE EP, Jani IV, Rosettie KL, Wood R, et al
    The value of point-of-Care CD4 and Laboratory viral Load in tailoring ART monitoring Strategies to resource limitations.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001586.
    >> Share

  382. FULCHER JA, Koukos G, Koutsioumpa M, Elliott J, et al
    Unique microRNA Expression in the Colonic Mucosa During Chronic HIV-1 Infection.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001582.
    >> Share

  383. SINGH KP, Crane M, Audsley J, Lewin SR, et al
    HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001574.
    >> Share

  384. LEMOINE M, Lacombe K, Bastard JP, Sebire M, et al
    Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients: results of the METAFIB study.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001587.
    >> Share

  385. HONG JJ, Silveira ELV, Amancha PK, Byrareddy SN, et al
    Early initiation of antiretroviral treatment post SIV infection does not resolve lymphoid tissue activation.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001576.
    >> Share

  386. VIEIRA VA, Avelino-Silva VI, Cerqueira NB, Costa DA, et al
    Asymptomatic anorectal Chlamydia trachomatis and Neisseria gonorrhoeae infections are associated with systemic CD8+ T cell activation.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001580.
    >> Share

  387. GIANELLA S, Chaillon A, Mutlu EA, Engen PA, et al
    Effect of CMV and EBV replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001579.
    >> Share

  388. SUN B, Dalvi P, Abadjian L, Tang N, et al
    Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001595.
    >> Share

  389. ELZI L, Erb S, Furrer H, Cavassini M, et al
    Adverse events of raltegravir and dolutegravir: a prospective analysis of 4,041 HIV-infected individuals from the Swiss HIV Cohort Study.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001590.
    >> Share

  390. LAFLEUR J, Bress AP, Rosenblatt L, Crook J, et al
    Cardiovascular outcomes among HIV-infected veterans receiving atazanavir: a US national historical cohort study.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001594.
    >> Share

  391. CHAPPELL CA, Lamorde M, Nakalema S, Chen B, et al
    Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001591.
    >> Share

  392. VANHOMMERIG JW, Bezemer D, Molenkamp R, Van Sighem AI, et al
    Limited overlap between phylogenetic HIV and HCV clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001592.
    >> Share

  393. GROSS R, Bellamy SL, Ratshaa B, Han X, et al
    CYP2B6 genotypes and early efavirenz-based hiv treatment outcomes in botswana.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001593.
    >> Share

  394. CAMACHO-GONZALEZ AF, Gillespie SE, Thomas-Seaton L, Frieson K, et al
    The Metropolitan Atlanta community adolescent rapid testing initiative study: closing the gaps in HIV care among youth in Atlanta, Georgia, USA.
    AIDS. 2017;31 Suppl 3:S267-S275.
    >> Share

  395. MARANO MR, Stein R, Williams WO, Wang G, et al
    HIV testing in nonhealthcare facilities among adolescent MSM.
    AIDS. 2017;31 Suppl 3:S261-S265.
    >> Share

  396. RURIA EC, Masaba R, Kose J, Woelk G, et al
    Optimizing linkage to care and initiation and retention on treatment of adolescents with newly diagnosed HIV infection.
    AIDS. 2017;31 Suppl 3:S253-S260.
    >> Share

  397. WAGNER AD, Mugo C, Bluemer-Miroite S, Mutiti PM, et al
    Continuous quality improvement intervention for adolescent and young adult HIV testing services in Kenya improves HIV knowledge.
    AIDS. 2017;31 Suppl 3:S243-S252.
    >> Share

  398. KAUFMAN MR, Dam KH, Van Lith LM, Hatzold K, et al
    Voluntary medical male circumcision among adolescents: a missed opportunity for HIV behavioral interventions.
    AIDS. 2017;31 Suppl 3:S233-S241.
    >> Share

  399. SHANAUBE K, Schaap A, Chaila MJ, Floyd S, et al
    Community intervention improves knowledge of HIV status of adolescents in Zambia: findings from HPTN 071-PopART for youth study.
    AIDS. 2017;31 Suppl 3:S221-S232.
    >> Share

  400. WILSON KS, Beima-Sofie KM, Moraa H, Wagner AD, et al
    "At our age, we would like to do things the way we want: " a qualitative study of adolescent HIV testing services in Kenya.
    AIDS. 2017;31 Suppl 3:S213-S220.
    >> Share

  401. INDRAVUDH PP, Sibanda EL, d'Elbee M, Kumwenda MK, et al
    'I will choose when to test, where I want to test': investigating young people's preferences for HIV self-testing in Malawi and Zimbabwe.
    AIDS. 2017;31 Suppl 3:S203-S212.
    >> Share

  402. DENISON JA, Pettifor A, Mofenson LM, Kasedde S, et al
    Youth engagement in developing an implementation science research agenda on adolescent HIV testing and care linkages in sub-Saharan Africa.
    AIDS. 2017;31 Suppl 3:S195-S201.
    >> Share

  403. WONG VJ, Murray KR, Phelps BR, Vermund SH, et al
    Adolescents, young people, and the 90-90-90 goals: a call to improve HIV testing and linkage to treatment.
    AIDS. 2017;31 Suppl 3:S191-S194.
    >> Share

    June 2017
  404. LEE JS, Cole SR, Richardson DB, Dittmer DP, et al
    Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation.
    AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001573.
    >> Share

  405. POPPE LK, Chunda-Liyoka C, Kwon EH, Gondwe C, et al
    HIV drug resistance in infants increases with changing PMTCT regimens.
    AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001569.
    >> Share

  406. GATANAGA H, Brumme ZL, Adland E, Reyes-Teran G, et al
    Potential for immune-driven viral polymorphisms to compromise antiretroviral-based pre-exposure prophylaxis for prevention of HIV-1 infection.
    AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001575.
    >> Share

  407. ALVAREZ-DEL ARCO D, Fakoya I, Thomadakis C, Pantazis N, et al
    High levels of post-migration HIV acquisition within nine European countries.
    AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001571.
    >> Share

  408. RAWAL S, Bogoch II
    Evaluation of non-sexual, non-needlestick, non-occupational HIV post-exposure prophylaxis cases.
    AIDS. 2017;31:1500-1502.
    >> Share

  409. FORHAN SE, Modi S, Houston JC, Broyles LN, et al
    Moving toward test and start: learning from the experience of universal antiretroviral therapy programs for HIV-infected pregnant/ breastfeeding women.
    AIDS. 2017;31:1489-1493.
    >> Share

  410. LANGEBEEK N, Kooij KW, Wit FW, Stolte IG, et al
    Impact of comorbidity and ageing on health-related quality of life in HIV-positive and HIV-negative individuals.
    AIDS. 2017;31:1471-1481.
    >> Share

  411. MCGRATH N, Grapsa E
    Does antiretroviral therapy change partnership dynamics and HIV risk behaviours among HIV-infected adults.
    AIDS. 2017;31:1451-1460.
    >> Share

  412. SORIGUE M, Garcia O, Tapia G, Baptista MJ, et al
    HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma.
    AIDS. 2017;31:1445-1449.
    >> Share

  413. GONCIULEA A, Wang R, Althoff KN, Palella FJ, et al
    An increased rate of fracture occurs a decade earlier in HIV+ compared with HIV- men.
    AIDS. 2017;31:1435-1443.
    >> Share

  414. UBAIDA-MOHIEN C, Lamberty B, Dickens AM, Mielke MM, et al
    Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients.
    AIDS. 2017;31:1365-1378.
    >> Share

  415. WAGNER AD, Njuguna IN, Andere R, Cranmer LM, et al
    Infant/child rapid serology tests fail to reliably assess HIV exposure among sick hospitalized infants.
    AIDS. 2017 Jun 12. doi: 10.1097/QAD.0000000000001562.
    >> Share

  416. FOSTER C, Pace M, Kaye S, Hopkins E, et al
    Early antiretroviral therapy reduces hiv dna following perinatal HIV infection.
    AIDS. 2017 Jun 12. doi: 10.1097/QAD.0000000000001565.
    >> Share

  417. GONCALVES PH, Uldrick TS, Yarchoan R
    HIV-associated Kaposi sarcoma and related diseases.
    AIDS. 2017 Jun 12. doi: 10.1097/QAD.0000000000001567.
    >> Share

  418. BASS JK, Opoka R, Familiar I, Nakasujja N, et al
    Randomized controlled trial of caregiver training for HIV-infected child neurodevelopment and caregiver well-being.
    AIDS. 2017 Jun 12. doi: 10.1097/QAD.0000000000001563.
    >> Share

  419. GARCIA-KNIGHT MA, Nduati E, Hassan AS, Nkumama I, et al
    Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants.
    AIDS. 2017 Jun 12. doi: 10.1097/QAD.0000000000001568.
    >> Share

  420. WILLIAMS-WIETZIKOSKI CA, So ID, Bull ME, Samleerat T, et al
    Genetic analyses of HIV env associated with uveitis in antiretroviral-naive individuals.
    AIDS. 2017 Jun 6. doi: 10.1097/QAD.0000000000001550.
    >> Share

  421. HARPER KN
    A decade of learning about the hiv reservoir: new insights into latent infection.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001559.
    >> Share

  422. MONTSERRAT M, Plana M, Guardo AC, Andres C, et al
    Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001560.
    >> Share

  423. DIRAJLAL-FARGO S, Sattar A, Kulkarni M, Bowman E, et al
    HIV positive youth who are perinatally infected have impaired endothelial function.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001556.
    >> Share

  424. THOMPSON CG, Fallon JK, Mathews M, Charlins P, et al
    Multimodal analysis of drug transporter expression in gastrointestinal tissue.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001554.
    >> Share

  425. JEAN-PHILIPPE P, Spiegel H, Gnanashanmugam D, Fitzgibbon J, et al
    HIV birth testing and linkage to care for HIV infected infants: workshop synopsis.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001561.
    >> Share

  426. ERLANDSON KM, Fiorillo S, Masawi F, Scherzinger A, et al
    Antiretroviral initiation is associated with increased skeletal muscle area and fat content.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001558.
    >> Share

  427. AKULLIAN A, Bershteyn A, Klein D, Vandormael A, et al
    Sexual partnership age-pairings and risk of HIV acquisition in rural South Africa: a population-based cohort study.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001553.
    >> Share

  428. BYRNE L, Sconza R, Foster C, Tookey PA, et al
    Pregnancy incidence and outcomes in women with perinatal HIV infection.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001552.
    >> Share

  429. DALAL S, Johnson C, Fonner V, Kennedy CE, et al
    Assisted HIV partner notification services: a systematic review and meta-analysis.
    AIDS. 2017 Jun 5. doi: 10.1097/QAD.0000000000001555.
    >> Share

  430. DALLA PRIA A, Merchant S, Bower M
    Oncological challenges for an ageing population living with HIV.
    AIDS. 2017;31 Suppl 2:S185-S189.
    >> Share

  431. SMITH JM, Flexner C
    The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development.
    AIDS. 2017;31 Suppl 2:S173-S184.
    >> Share

  432. NIGHTINGALE S, Winston A
    Measuring and managing cognitive impairment in HIV.
    AIDS. 2017;31 Suppl 2:S165-S172.
    >> Share

  433. BOCCARA F
    Cardiovascular health in an aging HIV population.
    AIDS. 2017;31 Suppl 2:S157-S163.
    >> Share

  434. GUARALDI G, Lonardo A, Maia L, Palella FJ Jr, et al
    Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver.
    AIDS. 2017;31 Suppl 2:S147-S156.
    >> Share

  435. HAWKINS KL, Brown TT, Margolick JB, Erlandson KM, et al
    Geriatric syndromes: new frontiers in HIV and sarcopenia.
    AIDS. 2017;31 Suppl 2:S137-S146.
    >> Share

  436. GUARALDI G, Palella FJ Jr
    Clinical implications of aging with HIV infection: perspectives and the future medical care agenda.
    AIDS. 2017;31 Suppl 2:S129-S135.
    >> Share

  437. SABIN CA, Reiss P
    Epidemiology of ageing with HIV: what can we learn from cohorts?
    AIDS. 2017;31 Suppl 2:S121-S128.
    >> Share

  438. LAGATHU C, Cossarizza A, Bereziat V, Nasi M, et al
    Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers.
    AIDS. 2017;31 Suppl 2:S105-S119.
    >> Share

  439. TODESCO E, Demeret S, Calin R, Roque-Afonso AM, et al
    Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.
    AIDS. 2017;31:1346-1348.
    >> Share

  440. MCMAHON JH, Chang J, Tennakoon S, Dantanarayana A, et al
    Post-treatment control in an adult with perinatally acquired HIV following cessation of antiretroviral therapy.
    AIDS. 2017;31:1344-1346.
    >> Share

  441. ESSER S, Streeck H
    Preexposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:1344.
    >> Share

  442. FOX J, Collins S
    HIV prevention: response to pre-exposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:1343.
    >> Share

  443. MARSHALL BDL, Tate JP, McGinnis KA, Bryant KJ, et al
    Long-term alcohol use patterns and HIV disease severity.
    AIDS. 2017;31:1313-1321.
    >> Share

  444. RYOM L, Mocroft A, Kirk O, Reiss P, et al
    Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individuals.
    AIDS. 2017;31:1261-1270.
    >> Share

  445. GRIESBECK M, Valantin MA, Lacombe K, Samri-Hassimi A, et al
    Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
    AIDS. 2017;31:1223-1234.
    >> Share

  446. LECCA L, Galea J, Contreras CC, Millones AK, et al
    Challenges in tuberculosis/HIV management in a country with a concentrated HIV epidemic.
    AIDS. 2017;31:1207-1209.
    >> Share

    May 2017
  447. ROUGH K, Sun JW, Seage GR 3rd, Williams PL, et al
    Zidovudine use in pregnancy and congenital malformations: meta-analysis and Bayesian incorporation of medicaid data.
    AIDS. 2017 May 23. doi: 10.1097/QAD.0000000000001549.
    >> Share

  448. ALVAREZ A, Orden S, Andujar I, Collado-Diaz V, et al
    Cardiovascular toxicity of Abacavir: a clinical controversy in need of a pharmacological explanation.
    AIDS. 2017 May 23. doi: 10.1097/QAD.0000000000001547.
    >> Share

  449. TOBIN SC
    Recent Progress in Anti-HIV Broadly Neutralizing Antibody Research.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001544.
    >> Share

  450. O'MALLEY TK, Burdo TH, Robinson JA, Fitch KV, et al
    Acute hyperinsulinemia effects on systemic markers of immune activation in HIV.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001545.
    >> Share

  451. YOUN B, Shireman TI, Lee Y, Galarraga O, et al
    Ten-year trends in anti-retroviral therapy persistence among US medicaid beneficiaries, 2001-2010.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001541.
    >> Share

  452. RASMUSSEN TA, McMahon J, Chang JJ, Symons J, et al
    Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001540.
    >> Share

  453. BLASER N, Bertisch B, Kouyos RD, Calmy A, et al
    Impact of screening and ART on anal cancer incidence in HIV-positive men who have sex with men: mathematical modeling study.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001546.
    >> Share

  454. ALSAN M, Beshears J, Armstrong WS, Choi JJ, et al
    A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001543.
    >> Share

  455. OMORI R, Abu-Raddad LJ
    Sexual network drivers of HIV and herpes simplex virus type 2 (HSV-2) transmission: a comparative mathematical modeling analysis.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001542.
    >> Share

  456. GATHOGO EN, Shah S, Post FA
    Kidney transplant outcomes in HIV serodiscordant recipient pairs.
    AIDS. 2017;31:1199-1201.
    >> Share

  457. ORIKIIRIZA J, Nakawesi J, Kikaire B, Turitwenka D, et al
    Unmet needs persist in pediatric HIV programs: lessons from selected case studies in Uganda.
    AIDS. 2017;31:1196-1199.
    >> Share

  458. AL TABAA O, Audren V, Hayton E, Pertuiset E, et al
    Right hip and bilateral shoulder capsulitis in an HIV-infected individual treated with elvitegravir and cobicistat.
    AIDS. 2017;31:1195-1196.
    >> Share

  459. DUTTA A, Uno H, Holman A, Lorenz DR, et al
    Long-term nitrite inhalant exposure and cancer risk in MSM.
    AIDS. 2017;31:1169-1180.
    >> Share

  460. MONTGOMERY ET, van der Straten A, Chitukuta M, Reddy K, et al
    Acceptability and use of a dapivirine vaginal ring in a phase III trial.
    AIDS. 2017;31:1159-1167.
    >> Share

  461. MEIJIDE H, Pertega S, Rodriguez-Osorio I, Castro-Iglesias A, et al
    Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected.
    AIDS. 2017;31:1099-1107.
    >> Share

  462. VANPOUILLE C, Bernatchez JA, Lisco A, Arakelyan A, et al
    A common anti-CMV drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001532.
    >> Share

  463. TOBIN SC
    WHO provides additional guidance on HIV self-testing and partner notification.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001537.
    >> Share

  464. MORENO M, Caballero E, Mateus RM, Samba F, et al
    HIV drug resistance in Africa: an emerging problem that deserves urgent attention.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001536.
    >> Share

  465. CABY F
    CD4/CD8 ratio restoration in long-term treated HIV-1-infected individuals: Incidence and determinants.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001533.
    >> Share

  466. KENNEDY CE, Yeh PT, Pandey S, Betran AP, et al
    Elective cesarean section for women living with HIV: a systematic review of risks and benefits.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001535.
    >> Share

  467. SHANAUBE K, Schaap A, Floyd S, Phiri M, et al
    What works-reaching universal hiv testing: lessons from HPTN 071 (PopART) trial in Zambia.
    AIDS. 2017 May 3. doi: 10.1097/QAD.0000000000001514.
    >> Share

  468. COBAN H, Robertson K, Smurzynski M, Krishnan S, et al
    Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV+ individuals on their first suppressive regimen.
    AIDS. 2017 May 3. doi: 10.1097/QAD.0000000000001523.
    >> Share

  469. CREPAZ N, Dong B, Chen M, Hall I, et al
    Examination of HIV infection through heterosexual contact with partners who are known to be HIV infected in the United States, 2010-2015.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001526.
    >> Share

  470. GUNST JD, Tolstrup M, Sogaard OS
    Beyond antiretroviral therapy: Early interventions to control HIV-1 infection.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001524.
    >> Share

  471. KIM CJ, Rousseau R, Huibner S, Kovacs C, et al
    Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers: a randomized controlled trial.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001515.
    >> Share

  472. TRIPLETTE M, Sigel KM, Morris A, Shahrir S, et al
    Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients: Implications for lung cancer screening.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001529.
    >> Share

  473. LAL L, Audsley J, Murphy D, Fairley CK, et al
    Medication adherence, condom use and sexually transmitted infections in Australian PrEP users: interim results from the Victorian PrEP Demonstration Project.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001519.
    >> Share

  474. LONG LC, Maskew M, Brennan AT, Mongwenyana C, et al
    Initiating antiretroviral therapy for HIV at a patient's first clinic visit: A cost-effectiveness analysis of the RapIT randomized controlled trial.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001528.
    >> Share

  475. HOORNENBORG E, Achterbergh RCA, Schim Van Der Loeff MF, Davidovich U, et al
    Men who have sex with men starting pre-exposure prophylaxis (PrEP) are at risk of HCV infection: evidence from the Amsterdam PrEP study.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001522.
    >> Share

  476. ONOYA D, Sineke T, Brennan A, Long L, et al
    Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001517.
    >> Share

  477. ANDERSON DJ, Politch JA, Zeitlin L, Hiatt A, et al
    Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001521.
    >> Share

    April 2017
  478. WINSTON A, Julie F, Fidler S
    HIV cure strategies: response to ignore the central nervous system at your patients' peril.
    AIDS. 2017;31:1051-1052.
    >> Share

  479. LE GARFF G, Samri A, Lambert-Niclot S, Even S, et al
    Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.
    AIDS. 2017;31:1048-1051.
    >> Share

  480. MCLEAN FE, Gathogo E, Goodall D, Jones R, et al
    Alemtuzumab induction therapy in HIV-positive renal transplant recipients.
    AIDS. 2017;31:1047-1048.
    >> Share

  481. FRANCESCHI S, Clifford GM
    Cervical screening: toward an equal risk/equal management approach, irrespective of HIV status.
    AIDS. 2017;31:1045-1046.
    >> Share

  482. WAMBURA M, Mahler H, Grund JM, Larke N, et al
    Increasing voluntary medical male circumcision uptake among adult men in Tanzania.
    AIDS. 2017;31:1025-1034.
    >> Share

  483. BREGIGEON S, Galinier A, Zaegel-Faucher O, Cano CE, et al
    Frailty in HIV infected people: a new risk factor for bone mineral density loss.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001507.
    >> Share

  484. SCHAEFER R, Gregson S, Eaton JW, Mugurungi O, et al
    Age-disparate relationships and HIV incidence in adolescent girls and young women: evidence from a general-population cohort in Zimbabwe.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001506.
    >> Share

  485. GIBELLINI L, Pecorini S, de Biasi S, Bianchini E, et al
    HIV-DNA content in different CD4+ T cell subsets correlates with CD4: CD8 ratio or length of efficient treatment.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001510.
    >> Share

  486. LANGEBEEK N, Kooij KW, Wit FW, Stolte IG, et al
    Impact of co-morbidity and aging on health-related quality of life in HIV-positive and HIV-negative individuals.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001511.
    >> Share

  487. MAURICE JB, Patel A, Scott AJ, Patel K, et al
    Prevalence and risk factors of non-alcoholic fatty liver disease in HIV-monoinfection: a systematic review and meta-analysis.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001504.
    >> Share

  488. INZAULE SC, Hamers RL, Mukui I, Were K, et al
    Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001500.
    >> Share

  489. PUTCHAROEN O, Wattanachanya L, Sophonphan J, Siwamogsatham S, et al
    New-onset diabetes in hiv treated adults from thailand: predictors, long-term renal and cardiovascular outcomes.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001496.
    >> Share

  490. SWEENEY P, Gray SC, Purcell DW, Sewell J, et al
    Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001501.
    >> Share

  491. UBAIDA-MOHIEN C, Lamberty B, Dickens AM, Mielke MM, et al
    Informatic interrogation of CSF proteomic profiles from HIV-infected subjects implicates acute phase and complement systems in shifting cognitive status.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001503.
    >> Share

  492. MCGRATH N, Grapsa E
    Does ART change partnership dynamics and HIV risk behaviours among PLWH? A cohort study in KwaZulu-Natal, South Africa.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001502.
    >> Share

  493. FORHAN SE, Modi S, Houston JC, Broyles LN, et al
    Moving towards test and start: learning from the experience of universal ART programs for HIV-infected pregnant/breastfeeding women.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001498.
    >> Share

  494. LEPIK KJ, Harrigan PR, Yip B, Wang L, et al
    Emergent drug resistance with integrase strand transfer inhibitor-based regimens: Incidence and risk factors.
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001494.
    >> Share

  495. VAN BILSEN WP, van den Berg CH, Rijnders BJ, Brinkman K, et al
    Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in hiv-infected patients: a multicenter cohort study.
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001492.
    >> Share

  496. GONCIULEA A, Wang R, Althoff KN, Palella FJ, et al
    An Increased Rate of Fracture Occurs a Decade Earlier in HIV+ Compared to HIV- men in the Multicenter AIDS Cohort Study (MACS).
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001493.
    >> Share

  497. MAHY M, Penazzato M, Ciaranello A, Mofenson L, et al
    Improving estimates of children living with HIV from the Spectrum AIDS Impact Model.
    AIDS. 2017;31 Suppl 1:S13-S22.
    >> Share

  498. WILSON KC, Mhangara M, Dzangare J, Eaton JW, et al
    Does nonlocal women's attendance at antenatal clinics distort HIV prevalence surveillance estimates in pregnant women in Zimbabwe?
    AIDS. 2017;31 Suppl 1:S95-S102.
    >> Share

  499. SHENG B, Marsh K, Slavkovic AB, Gregson S, et al
    Statistical models for incorporating data from routine HIV testing of pregnant women at antenatal clinics into HIV/AIDS epidemic estimates.
    AIDS. 2017;31 Suppl 1:S87-S94.
    >> Share

  500. MASQUELIER B, Eaton JW, Gerland P, Pelletier F, et al
    Age patterns and sex ratios of adult mortality in countries with high HIV prevalence.
    AIDS. 2017;31 Suppl 1:S77-S85.
    >> Share

  501. MARSTON M, Nakiyingi-Miiro J, Kusemererwa S, Urassa M, et al
    The effects of HIV on fertility by infection duration: evidence from African population cohorts before antiretroviral treatment availability.
    AIDS. 2017;31 Suppl 1:S69-S76.
    >> Share

  502. EATON JW, Bao L
    Accounting for nonsampling error in estimates of HIV epidemic trends from antenatal clinic sentinel surveillance.
    AIDS. 2017;31 Suppl 1:S61-S68.
    >> Share

  503. NIU X, Zhang A, Brown T, Puckett R, et al
    Incorporation of hierarchical structure into estimation and projection package fitting with examples of estimating subnational HIV/AIDS dynamics.
    AIDS. 2017;31 Suppl 1:S51-S59.
    >> Share

  504. SILHOL R, Gregson S, Nyamukapa C, Mhangara M, et al
    Empirical validation of the UNAIDS Spectrum model for subnational HIV estimates: case-study of children and adults in Manicaland, Zimbabwe.
    AIDS. 2017;31 Suppl 1:S41-S50.
    >> Share

  505. ANDEREGG N, Johnson LF, Zaniewski E, Althoff KN, et al
    All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up.
    AIDS. 2017;31 Suppl 1:S31-S40.
    >> Share

  506. MAHIANE SG, Marsh K, Grantham K, Crichlow S, et al
    Improvements in Spectrum's fit to program data tool.
    AIDS. 2017;31 Suppl 1:S23-S30.
    >> Share

  507. STOVER J, Brown T, Puckett R, Peerapatanapokin W, et al
    Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators.
    AIDS. 2017;31 Suppl 1:S5-S11.
    >> Share

  508. CASE KK, Gregson S, Mahy M, Ghys PD, et al
    Editorial: methodological developments in the Joint United Nations Programme on HIV/AIDS estimates.
    AIDS. 2017;31 Suppl 1:S1-S4.
    >> Share

    March 2017
  509. MONTES ML, Olveira A, Ahumada A, Aldamiz T, et al
    Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001465.
    >> Share

  510. VALVERDE-VILLEGAS JM, Medeiros RM, Andrade KP, Jacovas VC, et al
    Novel genetic associations and gene-gene interactions of chemokine receptor and chemokine genetic polymorphisms in HIV/AIDS.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001491.
    >> Share

  511. SORIGUE M, Garcia O, Tapia G, Baptista MJ, et al
    HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001487.
    >> Share

  512. EKINS S, Mathews P, Saito EK, Diaz N, et al
    alpha-7-nicotinic acetylcholine receptor inhibition by indinavir: implications for cognitive dysfunction in treated HIV disease.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001488.
    >> Share

  513. BELLAVIA A, Williams PL, Dimeglio LA, Hazra R, et al
    Delay in sexual maturation in perinatally HIV-infected youth is mediated by poor growth.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001486.
    >> Share

  514. DE MENDOZA C, Cabezas T, Caballero E, Requena S, et al
    HIV-2 Epidemic in Spain - Challenges and Missing Opportunities.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001485.
    >> Share

  515. EL-DIWANY R, Breitwieser FP, Soliman M, Skaist AM, et al
    Intracellular HIV-1 rna and CD4+ t cell activation in patients starting antiretrovirals.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001480.
    >> Share

  516. YU C, Seaton M, Letendre S, Heaton R, et al
    Plasma Dickkopf-related Protein 1, an antagonist of the Wnt pathway, is associated with HIV-associated neurocognitive impairment.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001481.
    >> Share

  517. RAJASURIAR R, Chong ML, Ahmad Bashah NS, Abdul Aziz SA, et al
    Significant health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy in Malaysia.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001475.
    >> Share

  518. STEKLER JD, Ure G, Dragavon J, Chang M, et al
    Detection of HIV RNA in dried blood spots and oral fluids.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001477.
    >> Share

  519. LECCA L, Galea J, Contreras CC, Millones AK, et al
    Challenges in TB/HIV management in a country with a concentrated HIV epidemic.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001471.
    >> Share

  520. IANTORNO M, Schar M, Soleimanifard S, Brown TT, et al
    Coronary artery endothelial dysfunction is present in HIV positive individuals without significant coronary artery disease.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001469.
    >> Share

  521. MARSHALL BD, Tate JP, Mcginnis KA, Bryant KJ, et al
    Long-term alcohol use patterns and HIV disease severity: A joint trajectory analysis.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001473.
    >> Share

  522. HASSAN AS, Pybus OG, Sanders EJ, Albert J, et al
    Defining HIV-1 transmission clusters based on sequence data: a systematic review and perspectives.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001470.
    >> Share

  523. RYOM L, Mocroft A, Kirk O, Reiss P, et al
    Predictors of eGFR progression, stabilisation or improvement after chronic renal impairment in HIV-positive individuals.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001464.
    >> Share

  524. WAMBURA M, Mahler H, Grund JM, Larke N, et al
    Increasing voluntary medical male circumcision (VMMC) uptake among adult men in Tanzania: A randomised controlled trial.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001440.
    >> Share

  525. MAHALINGASIVAM V, Gathogo E, Bramham K, Post FA, et al
    Successful pregnancy in an HIV-positive kidney transplant recipient.
    AIDS. 2017;31:872-873.
    >> Share

  526. JINDAL AK, Ahluwalia J, Sharma A, Dhawan S, et al
    HIV-infected children with hepatomegaly and ascites: is there something more than an infection?
    AIDS. 2017;31:870-872.
    >> Share

  527. GOEDERT JJ
    The microbiota and HIV: shedding light on dark matters.
    AIDS. 2017;31:863-865.
    >> Share


  528. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe.
    AIDS. 2017;31:835-846.
    >> Share

  529. PUSKAS CM, Kaida A, Miller CL, Zhang W, et al
    The adherence gap: a longitudinal examination of men's and women's antiretroviral therapy adherence in British Columbia, 2000-2014.
    AIDS. 2017;31:827-833.
    >> Share

  530. WINCKELMANN A, Barton K, Hiener B, Schlub TE, et al
    Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations.
    AIDS. 2017;31:771-779.
    >> Share

  531. OZANNE A, Duffau P, Dauchy FA, Rigothier C, et al
    Activation, senescence and inflammation markers in HIV patients: association with renal function.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001461.
    >> Share

  532. MEIJIDE H, Pertega S, Rodriguez-Osorio I, Castro-Iglesias A, et al
    Increased incidence of cancer observed in HIV/HCV-coinfected patients versus HIV-monoinfected, 1993-2014.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001448.
    >> Share

  533. PRICE H, Dunn D, Zachary T, Vudriko T, et al
    Hepatitis B serological markers and plasma DNA concentrations: baseline results from the DART trial.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001454.
    >> Share

  534. GRIESBECK M, Valantin MA, Lacombe K, Samri-Hassimi A, et al
    HCV drives increased type I IFN-associated impairments associated to fibrosis severity in ART-treated HIV-1-HCV coinfected individuals.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001455.
    >> Share

  535. ROBBINS HA, Strickler HD, Massad LS, Pierce CB, et al
    Cervical cancer screening intervals and management for women living with HIV: A risk benchmarking approach.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001450.
    >> Share

  536. JIN F, Roberts JM, Grulich AE, Poynten IM, et al
    The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001462.
    >> Share

  537. SAMUELS R, Bayerri CR, Sayer JA, Price DA, et al
    TDF associated renal tubular dysfunction: non-invasive assessment of mitochondrial injury.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001466.
    >> Share

  538. MOORE CB, Capparelli EV, Samson P, Bwakura-Dangarembizi M, et al
    CYP2B6 Genotype-directed dosing is required for optimal efavirenz exposure in children 3 to 36 months with HIV infection.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001463.
    >> Share

  539. MONTGOMERY ET, van der Straten A, Chitukuta M, Reddy K, et al
    "It's inside my body and it's mine".
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001452.
    >> Share

  540. MUKANDAVIRE C, Low A, Mburu G, Trickey A, et al
    Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001458.
    >> Share

  541. DUTTA A, Uno H, Holman A, Lorenz DR, et al
    Long-term nitrite inhalant exposure and cancer risk in men who have sex with men: a prospective cohort study.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001451.
    >> Share

  542. GAGNEUX-BRUNON A, Rochereau N, Botelho-Nevers E, Lucht F, et al
    Humoral responses against HIV in male genital tract: role in sexual transmission and perspectives for preventive strategies.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001460.
    >> Share

  543. MCALLISTER J, Towns JM, Mcnulty A, Pierce AB, et al
    Dolutegravir with tenofovir disoproxil fumarate - emtricitabine as HIV post-exposure prophylaxis in gay and bisexual men.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001447.
    >> Share

  544. MANGAL TD
    Joint estimation of CD4 progression and survival in untreated individuals with HIV-1 infection: A pooled analysis of data from 25 countries.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001437.
    >> Share

  545. MOTA TM, Rasmussen TA, Rhodes A, Tennakoon S, et al
    No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001442.
    >> Share

  546. YANG OO, Cumberland WG, Escobar R, Liao D, et al
    Demographics and natural history of HIV-1-infected spontaneous controllers of viremia: extremes on a continuum.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001443.
    >> Share

  547. KANTHULA R, Rossouw T, Feucht UD, Van Dyk G, et al
    Persistence of HIV-drug-resistance among South African Children given Nevirapine to Prevent Mother-to-Child-Transmission.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001446.
    >> Share

  548. KONG X, Kigozi G, Ssekasanvu J, Nalugoda F, et al
    Medical male circumcision coverage in Rakai, Uganda.
    AIDS. 2017;31:735-737.
    >> Share

  549. CZAICKI NL, Holmes CB, Sikazwe I, Bolton C, et al
    Nonadherence to antiretroviral therapy among HIV-infected patients in Zambia is concentrated among a minority of patients and is highly variable across clinics.
    AIDS. 2017;31:689-696.
    >> Share

  550. HARAWA NT, Holloway IW, Leibowitz A, Weiss R, et al
    Serious concerns regarding a meta-analysis of preexposure prophylaxis use and STI acquisition.
    AIDS. 2017;31:739-740.
    >> Share

  551. LINNEMAYR S, Stecher C, Mukasa B
    Behavioral economic incentives to improve adherence to antiretroviral medication.
    AIDS. 2017;31:719-726.
    >> Share

  552. TOMESCU C, Tebas P, Montaner LJ
    IFN-alpha augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    AIDS. 2017;31:613-622.
    >> Share

  553. TOBIN SC
    Evaluating the generalizability of clinical trials of direct-acting antivirals for HIV/HCV-coinfection.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001439.
    >> Share

  554. BURGOS J, Curran A, Landolfi S, Guelar A, et al
    Risk factors of high-grade anal intraepithelial neoplasia recurrence in HIV-infected men who have sex with men.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001433.
    >> Share

  555. MARCUS JL, Leyden WA, Chao CR, Horberg MA, et al
    Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001434.
    >> Share

  556. TORIBIO M, Fitch KV, Sanchez L, Burdo TH, et al
    Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in intrepid: a randomized trial in HIV.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001427.
    >> Share

  557. KIRKEGAARD-KLITBO DM, Mejer N, Knudsen TB, Moller HJ, et al
    Soluble CD163 Predicts Incident Chronic Lung, Kidney and Liver Disease in HIV Infection.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001432.
    >> Share

  558. MAHEU-GIROUX M, Tanser F, Boily MC, Pillay D, et al
    Determinants of time from HIV infection to linkage-to-care in rural KwaZulu-Natal, South Africa.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001435.
    >> Share

    February 2017
  559. BENGTSON AM, Pence BW, Moore R, Mimiaga MJ, et al
    The relationship between ever reporting depressive symptoms and all-cause mortality in a cohort of HIV-infected adults in routine care.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001431.
    >> Share

  560. BRYANT AK, Moore DJ, Burdo TH, Lakritz JR, et al
    Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001425.
    >> Share

  561. VESA J, Chaillon A, Wagner GA, Anderson CM, et al
    Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001445.
    >> Share


  562. First evidence of intra-familial transmission of an HIV-1 M/O intergroup recombinant virus: Erratum.
    AIDS. 2017;31:601.
    >> Share

  563. KASIRYE RP, Grosskurth H, Munderi P, Levin J, et al
    Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults.
    AIDS. 2017;31:577-582.
    >> Share

  564. COMBES JD, Clifford GM, Egger M, Cavassini M, et al
    Human papillomavirus antibody response following HAART initiation among MSM.
    AIDS. 2017;31:561-569.
    >> Share

  565. TAKUVA S, Brown AE, Pillay Y, Delpech V, et al
    The continuum of HIV care in South Africa: implications for achieving the second and third UNAIDS 90-90-90 targets.
    AIDS. 2017;31:545-552.
    >> Share

  566. JOSE S, Nelson M, Phillips A, Chadwick D, et al
    Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir.
    AIDS. 2017;31:485-492.
    >> Share

  567. MANDAL S, Prathipati PK, Kang G, Zhou Y, et al
    Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission.
    AIDS. 2017;31:469-476.
    >> Share

  568. RAFIEI N, Woolley I, Korman TM, Chibo D, et al
    Integrase-resistant HIV in an antiretroviral-naive patient in Australia.
    AIDS. 2017;31:598-600.
    >> Share

  569. DENNEMAN L, Cohen S, Godfried MH, van Leeuwen E, et al
    In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply.
    AIDS. 2017;31:596-598.
    >> Share

  570. WEN Y, Li JZ
    Post-treatment HIV controllers or spontaneous controllers in disguise?
    AIDS. 2017;31:587-589.
    >> Share

    January 2017
  571. LACHATRE M, Pasquet A, Ajana F, Soudan B, et al
    HIV and hypogonadism: a new challenge for young-aged and middle-aged men on effective antiretroviral therapy.
    AIDS. 2017;31:451-453.
    >> Share

  572. SCHUSTER C, Binder C, Strassl R, Aichelburg MC, et al
    Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial function.
    AIDS. 2017;31:395-400.
    >> Share

  573. REID M, Ma Y, Scherzer R, Price JC, et al
    Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.
    AIDS. 2017;31:385-393.
    >> Share


  574. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.
    AIDS. 2017;31:375-384.
    >> Share

  575. AKUA T, Rahav G, Saragani Y, Hizi A, et al
    Removal of ribonucleotides by p53 protein incorporated during DNA synthesis by HIV-1 reverse transcriptase.
    AIDS. 2017;31:343-353.
    >> Share

  576. BORGHETTI A, Baldin G, Capetti A, Sterrantino G, et al
    Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients.
    AIDS. 2017;31:457-459.
    >> Share

  577. AHMAD A, Rinaldo CR
    A novel anti-HIV immunotherapy to cure HIV.
    AIDS. 2017;31:447-449.
    >> Share

  578. SORIANO V, Sherman KE, Barreiro P
    Hepatitis Delta and HIV Infection.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001424.
    >> Share

  579. SU S, Wang Q, Xu W, Yu F, et al
    A novel HIV-1 gp41 tripartite model for rational design of HIV-1 fusion inhibitors with improved antiviral activity.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001415.
    >> Share

  580. PATEL EU, Gianella S, Newell K, Tobian AA, et al
    Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001412.
    >> Share

  581. PINATO DJ, Pria AD, Sharma R, Bower M, et al
    Hepatocellular carcinoma: an evolving challenge in viral hepatitis and HIV co-infection.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001422.
    >> Share

  582. LIFSON AR, Grund B, Gardner EM, Kaplan R, et al
    Improved quality of life with immediate initiation of antiretroviral therapy in the strategic timing of antiretroviral therapy trial.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001417.
    >> Share

  583. CHEHOUD C, Stieh DJ, Bailey AG, Laughlin AL, et al
    Associations of the vaginal microbiota with HIV infection, bacterial vaginosis and demographic factors.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001421.
    >> Share

  584. SU T, Mutsaerts HJ, Caan MW, Wit FW, et al
    Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001414.
    >> Share

  585. CROOME N, Ahluwalia M, Hughes LD, Abas M, et al
    Patient-reported barriers and facilitators to antiretroviral adherence in Sub-Saharan Africa: a systematic review.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001416.
    >> Share

  586. JOSHI PH, Miller PE, Martin SS, Jones SR, et al
    Greater remnant lipoprotein cholesterol reduction with pitavastatin compared to pravastatin in HIV-infected patients: The INTREPID trial.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001423.
    >> Share

  587. NOWAK RG, Bentzen SM, Ravel J, Crowell TA, et al
    Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected men who have sex with men (MSM) in Nigeria.
    AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001409.
    >> Share

  588. PUSKAS CM, Kaida A, Miller CL, Zhang W, et al
    The gender gap: a longitudinal examination of men's and women's art adherence in british columbia, 2000-2014.
    AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001408.
    >> Share


  589. Timing of cART initiation in Male and Female Migrants Living with HIV in Western Europe: an observational cohort study (1997-2013).
    AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001411.
    >> Share

  590. WINCKELMANN A, Barton K, Hiener B, Schlub TE, et al
    Romidepsin-induced HIV-1 viremia during effective ART contains identical viral sequences with few deleterious mutations.
    AIDS. 2017 Jan 19. doi: 10.1097/QAD.0000000000001400.
    >> Share

  591. MCCOY SI, Njau PF, Fahey C, Kapologwe N, et al
    Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV-infected adults in Tanzania: a randomized trial.
    AIDS. 2017 Jan 19. doi: 10.1097/QAD.0000000000001406.
    >> Share

  592. KRAFT JC, McConnachie LA, Koehn J, Kinman L, et al
    Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001405.
    >> Share

  593. MONTOYA JL, Iudicello J, Oppenheim HA, Fazeli PL, et al
    Coagulation imbalance and neurocognitive functioning in older HIV+ adults on suppressive antiretroviral therapy.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001404.
    >> Share

  594. BALINANG JM, Masvekar RR, Hauser KF, Knapp PE, et al
    Productive infection of human neural progenitor cells by R5 tropic HIV-1: opiate co-exposure heightens infectivity and functional vulnerability.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001398.
    >> Share

  595. SEREMBA E, Ssempijja V, Kalibbala S, Gray RH, et al
    Hepatitis B incidence and prevention with antiretroviral therapy among HIV positive individuals in Rakai, Uganda.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001399.
    >> Share

  596. BAI F, Iannuzzi F, Merlini E, Borghi L, et al
    Clinical and viro-immunological correlates of HIV associated neurocognitive disorders (HAND) in a cohort of antiretroviral-naive HIV-infected patients.
    AIDS. 2017;31:311-314.
    >> Share

  597. HOST KM, Horner MJ, van der Gronde T, Moses A, et al
    Kaposi's sarcoma in Malawi: a continued problem for HIV-positive and HIV-negative individuals.
    AIDS. 2017;31:318-319.
    >> Share

  598. BRENNAN AT, Bonawitz R, Gill CJ, Thea DM, et al
    Prioritizing health outcomes of HIV-exposed, uninfected children in low and middle-income countries: response to Powis et al.
    AIDS. 2017;31:317.
    >> Share

  599. POWIS KM, Slogrove AL, Mofenson L
    Protecting the health of our AIDS-free generation: beyond prevention of mother-to-child HIV transmission.
    AIDS. 2017;31:315-316.
    >> Share

  600. CACERES CF
    Educational attainment and intersectionality in the response to HIV antiretroviral treatment in Europe.
    AIDS. 2017;31:305-307.
    >> Share

  601. SAMJI H, Zhang W, Eyawo O, Jabbari S, et al
    Rates and predictors of injury in a population-based cohort of people living with HIV.
    AIDS. 2017;31:295-304.
    >> Share

  602. OMENGE ORANG'O E, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
    AIDS. 2017;31:233-240.
    >> Share

  603. CALZA L, Magistrelli E, Colangeli V, Borderi M, et al
    Significant association between statin-associated myalgia and vitamin d deficiency among treated hiv-infected patients.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001397.
    >> Share

  604. NUNN AS, Brinkley-Rubinstein L, Oldenburg CE, Mayer KH, et al
    Defining the HIV Pre-Exposure Prophylaxis Care Continuum.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001385.
    >> Share

  605. SABIN CA, Howarth A, Jose S, Hill T, et al
    Association between engagement in-care and mortality in HIV-positive persons: a cohort study.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001373.
    >> Share

  606. WEINBERG A, Mussi-Pinhata MM, Yu Q, Cohen RA, et al
    Excess respiratory viral infections and low antibody responses among HIV-exposed, uninfected infants.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001393.
    >> Share

  607. TOMESCU C, Tebas P, Montaner LJ
    IFN-alpha augments NK-mediated antibody-dependent cellular cytotoxicity (ADCC) of HIV-1 infected autologous CD4+ T cells regardless of MHC-I downregulation.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001380.
    >> Share

  608. FERREIRA MP, Coghill AE, Chaves CB, Bergmann A, et al
    Outcomes of cervical cancer among HIV-infected and uninfected women treated at the Brazilian National Institute of Cancer (2001-2013).
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001367.
    >> Share

  609. LINNEMAYR S, Stecher C, Mukasa B
    Behavioral economic incentives to improve adherence to antiretrovirals: early evidence from a randomized controlled trial in Uganda.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001387.
    >> Share

  610. MARTIN GE, Gossez M, Williams JP, Stohr W, et al
    Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001382.
    >> Share

  611. MAKAROVA N, Henning T, Taylor A, Dinh C, et al
    Topical tenofovir protects against vaginal SHIV infection in macaques co-infected with chlamydia trachomatis and trichomonas vaginalis.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001389.
    >> Share

  612. TINAGO W, Cotter AG, Sabin C, Macken A, et al
    Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative subjects.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001372.
    >> Share

  613. ANGIN M, Fathi A, King M, Ledoux MB, et al
    Acute HIV-1 infection is associated with increased plasma levels of heme oxygenase-1 (HO-1) and presence of HO-1-specific regulatory T cells.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001390.
    >> Share

  614. STREECK H, Verheyen J, Storim J, Dittmer U, et al
    Pre-exposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:176-177.
    >> Share

  615. SPECTOR SA, Rappaport J
    HIV cure strategists: ignore the central nervous system at your patients' peril.
    AIDS. 2017;31:167-168.
    >> Share


  616. Coinfection with HIV and hepatitis C virus in 229 children and young adults living in Europe.
    AIDS. 2017;31:127-135.
    >> Share

  617. NEWSUM AM, Ho CK, Lieveld FI, van de Laar TJ, et al
    The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.
    AIDS. 2017;31:105-112.
    >> Share

  618. M LE ROUX S, Jao J, Brittain K, Phillips TK, et al
    Tenofovir exposure in utero and linear growth in HIV-exposed, uninfected infants.
    AIDS. 2017;31:97-104.
    >> Share

  619. GAMA L, Abreu CM, Shirk EN, Price SL, et al
    Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques.
    AIDS. 2017;31:5-14.
    >> Share

  620. BRENNAN AT, Davies MA, Bor J, Wandeler G, et al
    Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
    AIDS. 2017;31:147-157.
    >> Share

    December 2016
  621. VENKATACHARI NJ, Jain S, Walker L, Bivalkar-Mehla S, et al
    Transcriptome analyses identify key cellular factors associated with HIV-1 associated neuropathogenesis in infected men.
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001379.
    >> Share

  622. PETERS L, Cozzi-Lepri A
    Is Response to Anti-HCV Treatment Predictive of Mortality in HCV/HIV Positive Patients?
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001378.
    >> Share

  623. BRENNER BG, Ibanescu RI, Hardy I, Stephens D, et al
    Large cluster outbreaks sustain the HIV epidemic among men having sex with men (MSM) in Quebec from 2002 to 2015.
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001383.
    >> Share

  624. HARPER KN
    New mouse models provide insights into how to design a more effective HIV vaccine.
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001371.
    >> Share

  625. HARPER KN
    Do HIV-infected children who do not develop AIDS hold clues to a cure?
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001370.
    >> Share

  626. HARPER KN
    To break patent or not to break patent: What is in the best interests of HIV patients in low-income countries?
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001369.
    >> Share

  627. DILLON SM, Kibbie J, Lee EJ, Guo K, et al
    Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001366.
    >> Share

  628. KROIDL A, Ello F, Mgaya J, Lennemann T, et al
    Virological efficacy of 24-weeks fozivudine based regimen in ART-naive patients from tanzania and cote d'Ivoire.
    AIDS. 2016.
    >> Share

  629. MORRIS A, Fitzpatrick M, Bertolet M, Qin S, et al
    Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease: A randomized pilot study.
    AIDS. 2016.
    >> Share

  630. SERRANO-VILLAR S, Vasquez-Dominguez E, Perez-Molina JA, Sainz T, et al
    HIV, HPV and microbiota: partners in crime?
    AIDS. 2016.
    >> Share

  631. DIRAJLAL-FARGO S, Alam SM, Sattar A, Kulkarni M, et al
    Comprehensive assessment of the arginine pathway and its relationship to inflammation in HIV.
    AIDS. 2016.
    >> Share

  632. LUNSKY Y, Durbin A, Brown HK, Bansal S, et al
    Health profiles and associated service use among adults with HIV and intellectual and developmental disabilities.
    AIDS. 2016.
    >> Share

  633. MERCHANTE N, Rivero-Juarez A, Tellez F, Merino D, et al
    Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis.
    AIDS. 2016.
    >> Share

  634. NELSON KN, Hui Q, Rimland D, Xu K, et al
    Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV+, treatment-naive U.S. veterans.
    AIDS. 2016.
    >> Share

    November 2016
  635. WESTREICH D, Cates J, Cohen M, Weber KM, et al
    Smoking, HIV, and risk of pregnancy loss.
    AIDS. 2016.
    >> Share

  636. PAZ-BAILEY G, Wejnert C, Mendoza MC, Prejean J, et al
    Response to diversification of risk-reduction strategies and reduced threat of HIV may explain increases in condomless sex.
    AIDS. 2016;30:2900-2901.
    >> Share

  637. KIPPAX S, Holt M
    Diversification of risk reduction strategies and reduced threat of HIV may explain increases in condomless sex.
    AIDS. 2016;30:2898-2899.
    >> Share

  638. AUTRAN B, Pogliaghi M, Katlama C
    Reply to Immunometabolism may provide insights into novel mechanisms of HIV reservoir persistence.
    AIDS. 2016;30:2896-2898.
    >> Share

  639. PALMER CS, Crowe SM
    Immunometabolism may provide new insights into novel mechanisms of HIV reservoir persistence.
    AIDS. 2016;30:2895-2896.
    >> Share

  640. DARCIS G, Coombs RW, Van Lint C
    Exploring the anatomical HIV reservoirs: role of the testicular tissue.
    AIDS. 2016;30:2891-2893.
    >> Share

  641. VASYLYEVA TI, Friedman SR, Lourenco J, Gupta S, et al
    Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects.
    AIDS. 2016;30:2885-2890.
    >> Share

  642. DE BOER MG, van den Berk GE, van Holten N, Oryszcyn JE, et al
    Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice.
    AIDS. 2016;30:2831-2834.
    >> Share

  643. TORT O, Sanchez-Palomino S, Escriba T, Calvo C, et al
    omega-3 supplementation in HIV-1-infected individuals with unsuppressed viral load: cause for caution?
    AIDS. 2016;30:2733-2735.
    >> Share

  644. BRENNER B, Wainberg MA
    We need to use the best antiretroviral drugs worldwide to prevent HIV drug resistance.
    AIDS. 2016;30:2725-2727.
    >> Share

  645. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
    AIDS. 2016;30:2715-2723.
    >> Share

  646. KIM AA, Mukui I, Young PW, Mirjahangir J, et al
    Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment.
    AIDS. 2016;30:2685-2695.
    >> Share

  647. LODI S, Sharma S, Lundgren JD, Phillips AN, et al
    The per-protocol effect of immediate versus deferred antiretroviral therapy initiation.
    AIDS. 2016;30:2659-2663.
    >> Share

  648. DE BIASI S, Bianchini E, Nasi M, Digaetano M, et al
    Th1 and Th17 proinflammatory profile characterizes invariant natural killer T cells in virologically suppressed HIV+ patients with low CD4+/CD8+ ratio.
    AIDS. 2016;30:2599-2610.
    >> Share

  649. VANCE DE
    Interpreting the influence of race and cognitive activity on neurocognition in adults aging with HIV.
    AIDS. 2016.
    >> Share

  650. YOUNAS M, Carrat F, Finge S, Desaint C, et al
    Immune activation, smoking, and vaccine response.
    AIDS. 2016.
    >> Share

  651. VIGANO S, Negron JJ, Tse S, Chowdhury FZ, et al
    HLA-G+ HIV-1-specific CD8 T cells are associated with HIV-1 immune control.
    AIDS. 2016.
    >> Share

  652. BUTTERFIELD TR, Hanna DB, Kaplan RC, Kizer JR, et al
    Increased glucose transporter-1 EXPRESSION on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease.
    AIDS. 2016.
    >> Share

  653. GOSSELIN A, Wiche Salinas TR, Planas D, Wacleche VS, et al
    HIV persists in CCR6+CD4+ T-cells from colon and blood during antiretroviral therapy.
    AIDS. 2016.
    >> Share

  654. KRUEGER KR, Adeyemi O, Leurgans S, Shah RC, et al
    Association of cognitive activity and neurocognitive function in blacks and whites with HIV.
    AIDS. 2016.
    >> Share

  655. SELVA KJ, Kent SJ, Parsons MS
    Modulation of innate and adaptive cellular immunity relevant to HIV-1 vaccine design by seminal plasma.
    AIDS. 2016.
    >> Share

  656. SUDFELD CR, Kaaya S, Gunaratna NS, Mugusi F, et al
    Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV.
    AIDS. 2016.
    >> Share

  657. SHIAU S, Strehlau R, Technau KG, Patel F, et al
    Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.
    AIDS. 2016.
    >> Share

  658. GUELER A, Moser A, Calmy A, Gunthard HF, et al
    Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.
    AIDS. 2016.
    >> Share

  659. MOFENSON LM, Baggaley RC, Mameletzis I
    Tenofovir Disoproxil Fumarate Safety for Women and their Infants during Pregnancy and Breastfeeding: Systematic Review.
    AIDS. 2016.
    >> Share

  660. ORANG'O O, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of VIA, Pap smear, or HR-HPV testing in women living with HIV/AIDS for post-treatment cervical cancer screening: same tests, different priorities.
    AIDS. 2016.
    >> Share

  661. GREEN N, Hoenigl M, Chaillon A, Anderson CM, et al
    Partner services in adults with acute and early HIV infection, San Diego, 1996-2014.
    AIDS. 2016.
    >> Share

  662. KARDASHIAN A, Ma Y, Scherzer R, Price JC, et al
    Sex differences in the association of HIV infection with hepatic steatosis.
    AIDS. 2016.
    >> Share

  663. BRAND D, Capsec J, Chaillon A, Cazein F, et al
    HIV surveillance combining an assay for identification of very recent infection and phylogenetic analyses on dried spots.
    AIDS. 2016.
    >> Share

  664. NAKAGAWA F, Phillips A
    An epidemiological modelling study to estimate the composition of HIV-positive populations including migrants from endemic settings: an application in the UK.
    AIDS. 2016.
    >> Share

  665. SAMJI H, Zhang W, Eyawo O, Jabbari S, et al
    Rates and predictors of injury in a population-based cohort of people living with HIV: trends and disparities from 1996 to 2013.
    AIDS. 2016.
    >> Share

  666. CHRISTOPOULOS K, Hartogensis W, Glidden DV, Pilcher CD, et al
    The lorenz curve: a novel method for understanding viral load distribution at the population level.
    AIDS. 2016.
    >> Share

  667. PELUSO MJ, Valcour V, Phanuphak N, Ananworanich J, et al
    Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.
    AIDS. 2016.
    >> Share

    October 2016
  668. MIRKOVIC KR, Rivadeneira ED, Broyles LN
    Children and alternative service delivery models: a case for inclusion.
    AIDS. 2016;30:2569-2570.
    >> Share

  669. UNAL G, Mourez T, Leoz M, Alessandri-Gradt E, et al
    First report of transmission of a highly resistant strain of HIV-1 group O.
    AIDS. 2016;30:2565-2568.
    >> Share

  670. ZOLLA-PAZNER S
    Non-neutralizing antibody functions for protection and control HIV in humans and SIV and SHIV in non-human primates.
    AIDS. 2016;30:2551-2553.
    >> Share

  671. BAUTISTA-ARREDONDO S, Sosa-Rubi SG, Opuni M, Contreras-Loya D, et al
    Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission.
    AIDS. 2016;30:2495-2504.
    >> Share

  672. OLIVER NT, Hartman CM, Kramer JR, Chiao EY, et al
    Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals.
    AIDS. 2016;30:2469-2476.
    >> Share

  673. FRIEDMAN EE, Duffus WA
    Chronic health conditions in Medicare beneficiaries 65 years and older with HIV infection.
    AIDS. 2016;30:2529-2536.
    >> Share

  674. MARSTON M, Nakiyingi-Miiro J, Kusemererwa S, Urassa M, et al
    The effects of HIV on fertility by infection duration: evidence from African population cohorts before ART availability: Fertility by duration of HIV infection.
    AIDS. 2016.
    >> Share

  675. BRENNAN AT, Davies MA, Bor J, Wandeler G, et al
    Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
    AIDS. 2016.
    >> Share

  676. SPRENGER HG, Bierman WF, Martes MI, Graaff R, et al
    Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events.
    AIDS. 2016.
    >> Share

  677. HARPER KN
    New research on using CRISPR/Cas9 to treat HIV.
    AIDS. 2016.
    >> Share

  678. GIANELLA S, Taylor J, Brown TR, Kaytes A, et al
    Can research at the end-of-life be a useful tool to advance HIV cure?
    AIDS. 2016.
    >> Share

  679. M LE ROUX S, Jao J, Brittain K, Phillips TK, et al
    Tenofovir exposure in utero and linear growth in HIV exposed, uninfected infants: a prospective study.
    AIDS. 2016.
    >> Share

  680. CHOPERA DR, Ntale R, Ndabambi N, Garrett N, et al
    Early evolution of HLA-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C infected women.
    AIDS. 2016.
    >> Share

  681. MERCHANTE N, Ibarra S, Revollo B, Rodriguez-Arrondo F, et al
    Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients (RIS-HEP12/GEHEP-002 study).
    AIDS. 2016.
    >> Share

  682. TAKEMOTO JK, Miller TL, Wang J, Jacobson DL, et al
    Insulin Resistance in HIV-Infected Youth is associated with decreased mitochondrial respiration.
    AIDS. 2016.
    >> Share

  683. KELLY HA, Sawadogo B, Chikandiwa A, Segondy M, et al
    Epidemiology of High-risk Human Papillomavirus and Cervical Lesions in African women living with HIV/AIDS: Effect of Anti-Retroviral Therapy.
    AIDS. 2016.
    >> Share

  684. VAN DER WERF MJ, Kodmon C, Zucs P, Hollo V, et al
    Tuberculosis and HIV co-infection in Europe: looking at one reality from two angles.
    AIDS. 2016.
    >> Share

  685. DARCIS G, Bouchat S, Kula A, Van Driessche B, et al
    Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir.
    AIDS. 2016.
    >> Share

  686. AHRENSTORF G, Low HZ, Kniesch K, Ordonez D, et al
    LILRA3 deletion is a genetic risk factor of HIV infection.
    AIDS. 2016.
    >> Share

  687. HARPER KN
    The 2nd Durban Declaration draws attention to progress in the fight against HIV and work yet to do.
    AIDS. 2016.
    >> Share

  688. HARPER KN
    HIV-altered gut microbiome may be driving disease progression.
    AIDS. 2016.
    >> Share

  689. DILLON SM, Frank DN, Wilson CC
    The gut microbiome and HIV-1 pathogenesis: a two way street.
    AIDS. 2016.
    >> Share

  690. DOBRA A, Barnighausen T, Vandormael A, Tanser F, et al
    Space-time migration patterns and risk of HIV acquisition in rural South Africa: a population-based cohort study.
    AIDS. 2016.
    >> Share

    September 2016
  691. GUPTA SK, Kamendulis LM, Clauss MA, Liu Z, et al
    A randomized, placebo-controlled pilot trial of N-acetylcysteine on oxidative stress and endothelial function in HIV-infected older adults receiving antiretroviral treatment.
    AIDS. 2016;30:2389-91.
    >> Share

  692. LUZURIAGA K, Persaud D
    Treatment interruption after early-treated perinatal HIV-1 infection.
    AIDS. 2016;30:2381-3.
    >> Share

  693. BREW BJ
    Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment?
    AIDS. 2016;30:2379-80.
    >> Share

  694. DE BOER M, van den Berk G, van Holten N, Oryszczyn J, et al
    Intolerance of dolutegravir containing cART regimens in real life clinical practice.
    AIDS. 2016.
    >> Share

  695. TAO J, Qian HZ, Kipp AM, Ruan Y, et al
    Effects of depression and anxiety on antiretroviral therapy adherence among newly diagnosed hiv-infected chinese men who have sex with men.
    AIDS. 2016.
    >> Share

  696. BEDOYA LM, Beltran M, Obregon-Calderon P, Garcia-Perez J, et al
    Hydroxytyrosol. a new class of microbicide displaying broad anti HIV-1 activity.
    AIDS. 2016.
    >> Share

  697. SCHERZER R, Heymsfield SB, Rimland D, Powderly WG, et al
    Association of serum albumin and AST with 5-year all-cause mortality in HIV/HCV coinfection and HIV monoinfection.
    AIDS. 2016.
    >> Share

  698. SOEPNEL LM, Norris SA, Schrier VJ, Browne JL, et al
    The association between HIV, antiretroviral therapy and gestational diabetes mellitus: a systematic review and meta-analysis.
    AIDS. 2016.
    >> Share

  699. THORNE C, Turkova A, Indolfi G, Venturini E, et al
    Co-infection with HIV and HCV in 229 children and young adults living in Europe.
    AIDS. 2016.
    >> Share

  700. MURI L, Gamell A, Ntamatungiro AJ, Glass TR, et al
    Development of HIV drug resistance and therapeutic failure in children and adolescents in rural tanzania - an emerging public health concern.
    AIDS. 2016.
    >> Share

  701. JENABIAN MA, Costiniuk CT, Mehraj V, Ghazawi FM, et al
    Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults.
    AIDS. 2016.
    >> Share

  702. MUKHERJEE PK, Chen H, Patton LL, Evans S, et al
    Topical gentian violet compared to nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1 Infected participants.
    AIDS. 2016.
    >> Share

  703. GUARDO AC, Joe PT, Miralles L, Bargallo ME, et al
    Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix).
    AIDS. 2016.
    >> Share

  704. TELWATTE S, Brumme CJ, Hearps AC, Latham CF, et al
    Increasing Prevalence of Synonymous Mutations K65K and K66K in HIV-1 subtype B reverse transcriptase.
    AIDS. 2016.
    >> Share

  705. DE BIASI S, Bianchini E, Nasi M, Digaetano M, et al
    Th1 and Th17 pro-inflammatory profile characterizes iNKT cells in virologically suppressed HIV+ patients with low CD4/CD8 ratio.
    AIDS. 2016.
    >> Share

  706. DEL AMO J
    Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe (1996-2013): a collaborative cohort study.
    AIDS. 2016.
    >> Share

  707. PRENDERGAST AJ, Bwakura-Dangarembizi M, Mugyenyi P, Lutaakome J, et al
    Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis.
    AIDS. 2016.
    >> Share

  708. GAMA L, Abreu CM, Shirk EN, Price SL, et al
    Reactivation of SIV reservoirs in the brain of virally suppressed macaques.
    AIDS. 2016.
    >> Share

  709. ALAEI K, Paynter CA, Juan SC, Alaei A, et al
    Using PrEP, losing condoms? PrEP promotion may undermine safe sex.
    AIDS. 2016.
    >> Share

  710. NEWSUM AM, Ho CK, Lieveld FI, Van De Laar TJ, et al
    The hepatitis C virus NS3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.
    AIDS. 2016.
    >> Share

  711. LEVIN MJ, Lindsey JC, Kaplan SS, Schimana W, et al
    Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.
    AIDS. 2016.
    >> Share

  712. PINES HA, Wertheim JO, Liu L, Garfein RS, et al
    Concurrency and HIV transmission network characteristics among men who have sex with men with recent HIV infection.
    AIDS. 2016.
    >> Share

  713. GAY CL, Willis SJ, Cope AB, Kuruc JD, et al
    Fixed dose combination emtricitabine/tenofovir/efavirenz initiated during Acute HIV Infection; 96-week efficacy and durability.
    AIDS. 2016.
    >> Share

  714. HLEYHEL M, Goujon S, Sibiude J, Blanche S, et al
    In utero exposure to NELFINAVIR-EMS.
    AIDS. 2016.
    >> Share

  715. KUZNIK A, Iliyasu G, Habib AG, Musa BM, et al
    Initiation of antiretroviral therapy based on the 2015 WHO guidelines: A cost-effectiveness analysis in Nigeria, South Africa, Uganda and India.
    AIDS. 2016.
    >> Share

  716. RYLANCE J, Mchugh G, Metcalfe J, Mujuru H, et al
    Chronic lung disease in HIV-infected children established on antiretroviral therapy.
    AIDS. 2016.
    >> Share

  717. GRANT PM, Kitch D, McComsey GA, Collier AC, et al
    Long-term body composition changes in antiretroviral-treated HIV-infected individuals.
    AIDS. 2016.
    >> Share

  718. SCHNEIDER JA, Kozloski M, Michaels S, Skaathun B, et al
    Criminal justice involvement history is associated with better HIV care continuum metrics among a population-based sample of young black men who have sex with men.
    AIDS. 2016.
    >> Share


  719. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption: Erratum.
    AIDS. 2016;30:2259.
    >> Share

  720. VASSALLO M, De Monte A, Durant J, Dunais B, et al
    Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders.
    AIDS. 2016;30:2257-8.
    >> Share

  721. CAMASMIE HR, Leda SB, Lupi O, Lima RB, et al
    Chronic herpetic whitlow as the first manifestation of HIV infection.
    AIDS. 2016;30:2254-6.
    >> Share

  722. CUERVO G, Simonetti AF, Alegre O, Sanchez-Salado JC, et al
    Toxoplasma myocarditis: a rare but serious complication in an HIV-infected late presenter.
    AIDS. 2016;30:2253-4.
    >> Share

  723. RAJA SK, Aggarwal S, Raman KR, Minteer WB, et al
    From businesswoman to banana vendor: mental health implications of HIV stigma in Tanzania.
    AIDS. 2016.
    >> Share

  724. SCHRACK JA, Jacobson LP, Althoff KN, Erlandson KM, et al
    Effect of HIV-infection and cumulative viral load on age-related decline in grip strength.
    AIDS. 2016.
    >> Share

  725. ASBJORNSDOTTIR KH, Hughes JP, Wamalwa D, Langat A, et al
    Differences in virologic and immunologic response to antiretroviral therapy among HIV-1 infected infants and children.
    AIDS. 2016.
    >> Share

  726. LODI S, Sharma S, Lundgren JD, Phillips AN, et al
    The per-protocol effect of immediate vs. deferred ART initiation in the START randomized trial.
    AIDS. 2016.
    >> Share

  727. TJIAM MC, Sariputra L, Armitage JD, Taylor JP, et al
    Control of early HIV-1 infection associates with plasmacytoid DC-reactive opsonophagocytic IgG antibodies to HIV-1 p24.
    AIDS. 2016.
    >> Share

  728. BROWN LB, Havlir DV, Ayieko J, Mwangwa F, et al
    High levels of retention in care with streamlined care and universal test-and-treat in East Africa.
    AIDS. 2016.
    >> Share

  729. VUILLE-LESSARD E, Lebouche B, Lennox L, Routy JP, et al
    nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV mono-infected patients.
    AIDS. 2016.
    >> Share

  730. KELESIDIS T, Jackson N, McComsey GA, Wang X, et al
    Oxidized lipoproteins are associated with markers of inflammation andimmune activation in HIV-1 infection.
    AIDS. 2016.
    >> Share

  731. VILLABONA-ARENAS CJ, Vidal N, Guichet E, Serrano L, et al
    In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa.
    AIDS. 2016.
    >> Share

    August 2016
  732. GUPTA SK, Dube MP, Stein JH, Clauss MA, et al
    A pilot trial of pentoxifylline on endothelial function and inflammation in HIV-infected patients initiating antiretroviral therapy.
    AIDS. 2016;30:2139-42.
    >> Share

  733. MILLARD JD, Henry J, Rizvi SS, Nelson M, et al
    Direct-acting antivirals for acute hepatitis C in HIV-infected MSM.
    AIDS. 2016;30:2137-9.
    >> Share

  734. DENNEMAN L, Cohen S, Godfried MH, van Leeuwen E, et al
    In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants.
    AIDS. 2016;30:2135-7.
    >> Share

  735. BRADLEY H, Mattson CL, Beer L, Huang P, et al
    Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection.
    AIDS. 2016;30:2117-24.
    >> Share

  736. MULANOVICH VE, Desai PA, Popat UR
    Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies: report of 5 cases after 2010.
    AIDS. 2016.
    >> Share

  737. ALVAREZ H, Marino A, Garcia-Rodriguez JF, Vilas-Sueiro A, et al
    Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers.
    AIDS. 2016.
    >> Share

  738. WAGNER GA, Chaillon A, Liu S, Franklin DR Jr, et al
    HIV-associated neurocognitive disorder is associated with HIV-1 dual infection.
    AIDS. 2016.
    >> Share

  739. SMITH JA, Daniel R
    Human vaginal fluid contains exosomes that have an inhibitory effect on an early step of the HIV-1 life cycle.
    AIDS. 2016.
    >> Share

  740. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining TB/HIV co-epidemic.
    AIDS. 2016.
    >> Share

  741. MOSEHOLM E, Helleberg M, Nordly SB, Rosenfeldt V, et al
    Hospital admission among HIV-exposed uninfected children compared to HIV-unexposed children - a nationwide cohort study.
    AIDS. 2016.
    >> Share

  742. TCHOUNGA BK, Hnge BL, Eholie SP, Coffie PA, et al
    Effect of sex and age on outcomes among hiv-2 infected patients starting antiretroviral therapy in west africa: a multicentre cohort study.
    AIDS. 2016.
    >> Share

  743. HIRA S, Piot P
    The counter effects of the ebola epidemic on control and treatment of HIV/AIDS, tuberculosis, and malaria in West Africa.
    AIDS. 2016.
    >> Share

  744. BUGGERT M, Frederiksen J, Lund O, Betts MR, et al
    CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection.
    AIDS. 2016.
    >> Share

  745. EMMER KL, Wieczorek L, Tuyishime S, Molnar S, et al
    Antibody responses to prime-boost vaccination with an HIV-1 gp145 Env protein and chimpanzee adenovirus vectors expressing HIV-1 gp140.
    AIDS. 2016.
    >> Share

  746. KIM AA, Mukui I, Young PW, Mirjahangir J, et al
    Undisclosed HIV infection and art use in the kenya AIDS indicator survey 2012: relevance to targets for HIV diagnosis and treatment in kenya.
    AIDS. 2016.
    >> Share

  747. POLIS CB, Phillips SJ, Hillier SL, Achilles SL, et al
    Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?
    AIDS. 2016.
    >> Share

  748. POLIS CB, Curtis KM, Hannaford PC, Phillips SJ, et al
    Update on hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence, 2016.
    AIDS. 2016.
    >> Share

  749. GILL AL, Green SA, Abdullah S, Le Saout C, et al
    PD1/PD-L1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-PD-L1 (Avelumab).
    AIDS. 2016.
    >> Share

  750. ESCUDERO DJ, Lurie MN, Mayer KH, Weinreb C, et al
    Acute HIV infection transmission among people who inject drugs in a mature epidemic setting.
    AIDS. 2016.
    >> Share

  751. OLIVER NT, Hartman CM, Kramer JR, Chiao EY, et al
    Statin drugs decrease progression to cirrhosis in HIV/HCV co-infected individuals.
    AIDS. 2016.
    >> Share

  752. THOMAS GP, Li X, Post WS, Jacobson LP, et al
    Associations between antiretroviral use and subclinical coronary atherosclerosis.
    AIDS. 2016.
    >> Share

  753. GOWDA C, Brown TT, Compher C, Forde KA, et al
    Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection.
    AIDS. 2016.
    >> Share

  754. KRUBINER CB, Faden RR, Cadigan RJ, Gilbert SZ, et al
    Advancing HIV research with pregnant women: navigating challenges and opportunities.
    AIDS. 2016.
    >> Share

    July 2016

  755. Long-term impact of HIV wasting on physical function: Erratum.
    AIDS. 2016;30:2007.
    >> Share


  756. Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection: Erratum.
    AIDS. 2016;30:2005.
    >> Share

  757. CACHAY E, Soriano V
    Is HIV still a special population for the treatment of hepatitis C?
    AIDS. 2016;30:2001-3.
    >> Share

  758. SCHALKWIJK S, Feiterna-Sperling C, Weizsacker K, Colbers A, et al
    Substantially lowered dolutegravir exposure in a treatment-experienced perinatally HIV-1-infected pregnant woman.
    AIDS. 2016;30:1999-2001.
    >> Share

  759. CHIODI F
    Pneumococcal vaccination of HIV-infected young adults is an important global priority.
    AIDS. 2016;30:1991-3.
    >> Share

  760. FRIEDMAN EE, Duffus WA
    Chronic health conditions in medicare beneficiaries 65 years and older with HIV infection.
    AIDS. 2016.
    >> Share

  761. MATEY EJ, Tokoro M, Mizuno T, Matsumura T, et al
    Positive correlation of HIV infection with Giardia intestinalis assemblage B but not with assemblage A in asymptomatic Kenyan children.
    AIDS. 2016.
    >> Share

  762. BAUTISTA-ARREDONDO S, Sosa-Rubi SG, Opuni M, Contreras-Loya D, et al
    Costs along the HTC and PMTCT service cascades: findings from Kenya, Rwanda, South Africa, and Zambia.
    AIDS. 2016.
    >> Share

  763. BRENNAN AT, Bonawitz R, Gill CJ, Thea D, et al
    A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared to HIV-unexposed uninfected infants and children.
    AIDS. 2016.
    >> Share

  764. SHAHMANESH M, Schultze A, Burns F, Kirk O, et al
    The cardiovascular risk management for people living with HIV in Europe: how well are we doing?
    AIDS. 2016.
    >> Share

  765. STOHR W, Dunn DT, Arenas-Pinto A, Orkin C, et al
    Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy in the PIVOT trial.
    AIDS. 2016.
    >> Share

  766. KASSANJEE R, Pilcher CD, Busch MP, Murphy G, et al
    Viral load criteria and threshold optimization to improve HIV incidence assay characteristics - a CEPHIA analysis.
    AIDS. 2016.
    >> Share


  767. HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls: Erratum.
    AIDS. 2016;30:1863.
    >> Share


  768. Assessing efficacy of a retention in care intervention among HIV patients with depression, anxiety, heavy alcohol consumption and illicit drug use: Erratum.
    AIDS. 2016;30:1861.
    >> Share

  769. ROKX C, Vella S, Pantaleo G, Levy Y, et al
    Unite forces to validate biomarkers in the quest for lasting HIV remission.
    AIDS. 2016;30:1859-60.
    >> Share

  770. DES JARLAIS DC, Carrieri P
    HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks: authors' reply.
    AIDS. 2016;30:1858-9.
    >> Share

  771. CAZEIN F, Pillonel J, Barin F, Jauffret-Roustide M, et al
    HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.
    AIDS. 2016;30:1857-8.
    >> Share

  772. BOYD A, Lacombe K, Girard PM
    An improved understanding of severe liver morbidity in HIV-infected individuals.
    AIDS. 2016;30:1843-5.
    >> Share

  773. AHMAD A, Mehraj V, Jenabian MA, Samarani S, et al
    Combination antiretroviral therapy and indoleamine 2,3-dioxygenase in HIV infections: challenges and new opportunities.
    AIDS. 2016;30:1839-41.
    >> Share

  774. YEK C, Gianella S, Plana M, Castro P, et al
    Standard vaccines increase HIV-1 transcription during antiretroviral therapy.
    AIDS. 2016.
    >> Share

  775. ARPADI SM, Shiau S, Strehlau R, Patel F, et al
    Efavirenz is associated with higher bone mass in South African children with HIV.
    AIDS. 2016.
    >> Share

  776. PARK SY, Mack WJ, Lee HY
    Enhancement of viral escape in HIV-1 Nef by STEP vaccination.
    AIDS. 2016.
    >> Share

  777. CHEW KW, Bhattacharya D
    Virologic and immunologic aspects of HIV-HCV coinfection.
    AIDS. 2016.
    >> Share

  778. EVANS C, Chasekwa B, Ntozini R, Humphrey JH, et al
    Head circumferences of children born to HIV-infected and HIV-uninfected mothers in Zimbabwe during the pre-ART era.
    AIDS. 2016.
    >> Share

  779. VOSS JE, Macauley MS, Rogers KA, Villinger F, et al
    Reproducing SIVDeltanef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines.
    AIDS. 2016.
    >> Share

  780. SAMRI A, Bacchus-Souffan C, Hocqueloux L, Avettand-Fenoel V, et al
    Polyfunctional HIV-specific T-cells in post-treatment controllers.
    AIDS. 2016.
    >> Share

  781. DE MONTEYNARD LA, Matheron S, Gilquin J, Pavie J, et al
    Influence of geographic origin, sex and HIV transmission group on the outcome of first-line combined antiretroviral therapy (cART) in France.
    AIDS. 2016.
    >> Share

    June 2016
  782. OLIVEIRA M, Ibanescu RI, Pham HT, Brenner B, et al
    The M184I/V and K65R nucleoside resistance mutations in HIV-1 prevent the emergence of resistance mutations against dolutegravir.
    AIDS. 2016.
    >> Share

  783. HONTELEZ JA, Chang AY, Ogbuoji O, Vlas SJ, et al
    Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: Investment needs, population health gains, and cost-effectiveness.
    AIDS. 2016.
    >> Share

  784. HARPER K
    The emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland.
    AIDS. 2016.
    >> Share

  785. ROBERTSON KR, Miyahara S, Lee A, Brown TT, et al
    Neurocognition in maraviroc- compared to tenofovir: a double blind randomized placebo controlled trial ACTG A5303.
    AIDS. 2016.
    >> Share

  786. DUARTE F, Miranda AC, Peres S, Diogo I, et al
    Transmitted drug resistance in drug-naive HIV-2 infected patients.
    AIDS. 2016;30:1687-8.
    >> Share

  787. GERVASONI C, Minisci D, Meraviglia P, Baldelli S, et al
    Determinants of bone diseases in tenofovir-treated HIV patients.
    AIDS. 2016;30:1686-7.
    >> Share

  788. HAGAN H, Jordan AE, Cleland CM
    Response to the calculation of population attributable fractions of risk factors for hepatitis C transmission: authors' reply.
    AIDS. 2016;30:1685.
    >> Share

  789. MOOG C, Mayr L, Tolstrup M
    New insights on the phenotype of HIV reservoirs.
    AIDS. 2016;30:1675-6.
    >> Share

  790. MAKUMBI FE, Ssempijja V, Sekasanvu J, Ssekubugu R, et al
    Postcoital penile washing and the risk of HIV acquisition in uncircumcised men.
    AIDS. 2016;30:1669-73.
    >> Share

  791. STERLING TR, Scott NA, Miro JM, Calvet G, et al
    Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.
    AIDS. 2016;30:1607-15.
    >> Share

  792. MOLDT B, Le KM, Carnathan DG, Whitney JB, et al
    Neutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques.
    AIDS. 2016;30:1543-51.
    >> Share

  793. KOJIMA N, Davey DJ, Klausner JD
    Pre-exposure prophylaxis for human immunodeficiency virus and sexually transmitted infection acquisition among men who have sex with men.
    AIDS. 2016.
    >> Share

  794. LESKO CR, Edwards JK, Moore RD, Lau B, et al
    A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of injection drug use.
    AIDS. 2016.
    >> Share

  795. FITCH KV, DeFilippi C, Christenson R, Srinivasa S, et al
    Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals.
    AIDS. 2016.
    >> Share

  796. DELVA W, Leventhal GE, Helleringer S
    Connecting the dots: network data and models in HIV epidemiology.
    AIDS. 2016.
    >> Share

  797. AMU S, Fievez V, Nozza S, Lopalco L, et al
    Dysfunctions in the migratory phenotype and properties of circulating immature transitional B cells during HIV-1 Infection.
    AIDS. 2016.
    >> Share

  798. YONG YK, Shankar EM, Solomon A, Spelman T, et al
    Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.
    AIDS. 2016.
    >> Share

  799. GARCIA M, Le Moal G, Godet C, Beraud G, et al
    First case report of renal improvement on tenofovir alafenamide in an HIV/hepatitis B virus-coinfected patient with adefovir-induced Fanconi's syndrome.
    AIDS. 2016;30:1487-8.
    >> Share

  800. KADEDE K, Ruel T, Kabami J, Ssemmondo E, et al
    Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya.
    AIDS. 2016.
    >> Share

  801. MUMMERT C, Hofmann C, Huckelhoven AG, Bergmann S, et al
    T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients.
    AIDS. 2016.
    >> Share

  802. VAN DEN KERKHOF TL, van Gils MJ, Boeser-Nunnink BD, Burger JA, et al
    Probability of N332 glycan occupancy on HIV-1 gp120 modulates sensitivity to broadly neutralizing antibodies.
    AIDS. 2016.
    >> Share

  803. FERGUSON D, Clarke S, Berry N, Almond N, et al
    Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic ART.
    AIDS. 2016.
    >> Share

    May 2016
  804. GIROMETTI N, Jones R, Levy J, McCormack S, et al
    Risks and benefits of HIV pre exposure prophylaxis with tenofovir/emtricitabine in an older man with co-morbidities.
    AIDS. 2016.
    >> Share

  805. JIN C, Peng X, Liu F, Cheng L, et al
    Interferon-induced SAMHD1 expression in astrocytes and microglia is mediated by miR-181a.
    AIDS. 2016.
    >> Share

  806. KAGAAYI J, Kong X, Kigozi G, Ssekubugu R, et al
    Self-selection of male circumcision clients and behaviors following circumcision in a service program in rakai, Uganda.
    AIDS. 2016.
    >> Share

  807. LONGENECKER CT, Sattar A, Gilkeson R, Mccomsey GA, et al
    Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
    AIDS. 2016.
    >> Share

  808. MONROE AK, Haberlen SA, Post WS, Palella FJ Jr, et al
    Cardiovascular disease risk scores' relationship to subclinical cardiovascular disease among HIV-infected and-uninfected men.
    AIDS. 2016.
    >> Share

  809. AKGUN KM, Tate JP, Oursler KK, Crystal S, et al
    Association of chronic obstructive pulmonary disease (COPD) with frailty measurements in HIV-infected and uninfected Veterans.
    AIDS. 2016.
    >> Share

  810. NGUYEN TP, Shukla S, Asaad R, Freeman ML, et al
    Responsiveness to IL-7 but not to IFN-alpha is diminished in CD4 T cells from treated HIV infected patients who experience poor CD4 T cell recovery.
    AIDS. 2016.
    >> Share

  811. ASAHCHOP EL, Akinwumi SM, Branton WG, Fujiwara E, et al
    Plasma microRNA profiling predicts HIV-associated neurocognitive disorder.
    AIDS. 2016.
    >> Share

  812. BREY FL, Seybold U, Kollan C, Bogner JR, et al
    Accelerated CD4 decline in untreated HIV-1 patients points toward increasing virulence over the course of the epidemic.
    AIDS. 2016.
    >> Share

  813. KOZLOWSKI HN, Lai ET, Havugimana PC, White C, et al
    Extracellular histones identified in crocodile blood inhibit in vitro HIV-1 infection.
    AIDS. 2016.
    >> Share

  814. WAMALWA D, Benki-Nugent S, Langat A, Tapia K, et al
    Treatment interruption after 2-year antiretroviral treatment (ART) initiated during acute/early HIV in infancy: a randomized trial.
    AIDS. 2016.
    >> Share

  815. OKULICZ JF, Boufassa F, Costagliola D, Ganesan A, et al
    Cancers In Elite Controllers: Appropriate Follow-up is Essential.
    AIDS. 2016.
    >> Share

  816. VASE MO, Ludvigsen M, Bendix K, Hamilton-Dutoit S, et al
    Proteomic profiling of pre-treatment serum from HIV infected patients identifies candidate markers predictive of lymphoma development.
    AIDS. 2016.
    >> Share

  817. HSU DC, Ma YF, Hur S, Li D, et al
    Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive ART.
    AIDS. 2016.
    >> Share

  818. CHEN P, Yi Z, Zhang W, Klotman ME, et al
    HIV infection-induced transcriptional program in renal tubular epithelial cells activates a CXCR2 driven CD4+ T cell chemotactic response.
    AIDS. 2016.
    >> Share

  819. JASKIEWICZ W, Oketcho V, Settle D, Frymus D, et al
    Investing in the health workforce to increase access to and use of HIV and AIDS services in Uganda.
    AIDS. 2016.
    >> Share

  820. ANGLEWICZ P, VanLandingham M, Manda-Taylor L, Kohler HP, et al
    Migration and HIV infection in malawi: A population-based longitudinal study.
    AIDS. 2016.
    >> Share

  821. JEAN K, Puren A, Cutler E, Singh B, et al
    Level of Viral Suppression and the Cascade of HIV Care in a South-African Semi-urban Setting in 2012.
    AIDS. 2016.
    >> Share

  822. CROWELL TA, Phanuphak N, Pinyakorn S, Kroon E, et al
    Virologic failure is uncommon after treatment initiation during acute HIV infection.
    AIDS. 2016.
    >> Share

  823. BACHLE SM, Malone DF, Buggert M, Karlsson AC, et al
    Elevated levels of iNKT cell and NK cell activation correlate with disease progression in HIV-1 and HIV-2 infections.
    AIDS. 2016.
    >> Share

    April 2016
  824. FIORE JR, Zoboli F, Di Stefano M, Faleo G, et al
    Impact of adding raltegravir to antiretroviral regimens in patients with blood viral suppression but persistent seminal viral shedding.
    AIDS. 2016;30:1144-6.
    >> Share

  825. ALVAREZ-ROMAN MT, Rivas Pollmar MI, Bernardino JI, Lozano ML, et al
    Thrombopoietin receptor agonists in conjunction with oseltamivir for immune thrombocytopenia.
    AIDS. 2016;30:1141-2.
    >> Share

    January 2016
  826. JANI IV, Quevedo JI, Tobaiwa O, Bollinger T, et al
    Use of mobile phone technology to improve the quality of point-of-care testing in a low-resource setting.
    AIDS. 2016;30:159-61.
    >> Share

  827. MOOIJ SH, van Santen DK, Geskus RB, van der Sande MA, et al
    The effect of HIV infection on anal and penile human papillomavirus incidence and clearance: a cohort study among MSM.
    AIDS. 2016;30:121-32.
    >> Share

  828. OLSTHOORN AV, Sivachandran N, Bogoch I, Kwantampora J, et al
    Barriers to the uptake of postexposure prophylaxis among Nairobi-based female sex workers.
    AIDS. 2016;30:99-103.
    >> Share

  829. COGHILL AE, Shiels MS, Rycroft RK, Copeland G, et al
    Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?
    AIDS. 2016;30:105-12.
    >> Share

  830. SCHURMANN D, Sobotha C, Gilmartin J, Robberechts M, et al
    A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals.
    AIDS. 2016;30:57-63.
    >> Share

  831. SAVAGE EJ, Lowndes CM, Sullivan AK, Back DJ, et al
    Effect of nondisclosure of HIV status in sexual health clinics on unlinked anonymous HIV prevalence estimates in England, 2005-2009.
    AIDS. 2016;30:145-9.
    >> Share

  832. CHOW FC, Boscardin WJ, Mills C, Ko N, et al
    Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals.
    AIDS. 2016;30:45-55.
    >> Share

  833. GESKUS RB, Gonzalez C, Torres M, Del Romero J, et al
    Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors.
    AIDS. 2016;30:37-44.
    >> Share

    September 2015
  834. KOETHE JR, Grome H, Jenkins CA, Kalams SA, et al
    The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy.
    AIDS. 2015.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016